{
    "abstract": "\u201cCross-reactivity\u201d (the observed immune response against pathogen types not specifically targeted by the vaccine antigen composition) and \u201ccross-protection\u201d (clinical protection against related non-vaccine microorganism types) are vaccinology concepts that are attracting renewed interest in the context of disease prevention. National health authorities are collecting mounting evidence of the importance of cross-reactivity. For some vaccines, this has been substantiated by cross-protection data from clinical studies and/or post-licensure data, where their introduction into immunization programmes has shown beneficial impacts on disease caused by related non-vaccine microorganisms. This knowledge has influenced the way new vaccines are designed, developed, and evaluated in real-life settings. Some of the new vaccines are now designed with the specific aim of having a greater breadth of protection. Ideal vaccine antigens therefore include epitopes with conserved homology across related pathogen types, because it is not always possible to include the antigens of all the individual types of a given pathogen species. The use of novel adjuvants with greater immunostimulatory properties can also contribute to improved overall vaccine cross-reactivity, as could the use of antigen delivery platforms. The growing body of evidence allows us to better understand the full impact of vaccines \u2013 beyond vaccine-type disease \u2013 which should be taken into consideration when assessing the full value of vaccination programmes.",
    "author_highlights": [
        {
            "endOffset": 15044,
            "sentence": "Cross-reactivity is common and important from a public health perspective.",
            "startOffset": 14970
        },
        {
            "endOffset": 15122,
            "sentence": "Real-world cross-protection data against non-vaccine types are now available.",
            "startOffset": 15045
        },
        {
            "endOffset": 15215,
            "sentence": "Clinical and economic impact assessments should include cross-protective effects of vaccine.",
            "startOffset": 15123
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Szarewski"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "Paulo",
                    "initial": "P.",
                    "last": "Naud"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Salmer\u00f3n"
                },
                {
                    "first": "Song Nan",
                    "initial": "S.N.",
                    "last": "Chow"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Apter"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Kitchener"
                },
                {
                    "first": "J\u00falio C.",
                    "initial": "J.C.",
                    "last": "Teixeira"
                },
                {
                    "first": "S. Rachel",
                    "initial": "S.R.",
                    "last": "Skinner"
                },
                {
                    "first": "Unnop",
                    "initial": "U.",
                    "last": "Jaisamrarn"
                },
                {
                    "first": "Genara",
                    "initial": "G.",
                    "last": "Limson"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Romanowski"
                },
                {
                    "first": "Fred Y.",
                    "initial": "F.Y.",
                    "last": "Aoki"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Willy A.J.",
                    "initial": "W.A.J.",
                    "last": "Poppe"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Diane M.",
                    "initial": "D.M.",
                    "last": "Harper"
                },
                {
                    "first": "Warner",
                    "initial": "W.",
                    "last": "Huh"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Hardt"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Struyf"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Dubin"
                },
                {
                    "first": "Matti",
                    "initial": "M.",
                    "last": "Lehtinen"
                }
            ],
            "doi": "10.1016/S1470-2045(11)70287-X",
            "firstpage": "100",
            "issn": "14702045",
            "lastpage": "110",
            "pmid": "22075170",
            "pub_year": 2012,
            "title": "Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial",
            "volume": "13"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Julian P.T.",
                    "initial": "J.P.T.",
                    "last": "Higgins"
                },
                {
                    "first": "Karla",
                    "initial": "K.",
                    "last": "Soares-Weiser"
                },
                {
                    "first": "Jos\u00e9 A.",
                    "initial": "J.A.",
                    "last": "L\u00f3pez-L\u00f3pez"
                },
                {
                    "first": "Artemisia",
                    "initial": "A.",
                    "last": "Kakourou"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Chaplin"
                },
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Christensen"
                },
                {
                    "first": "Natasha K.",
                    "initial": "N.K.",
                    "last": "Martin"
                },
                {
                    "first": "Jonathan A.C.",
                    "initial": "J.A.C.",
                    "last": "Sterne"
                },
                {
                    "first": "Arthur L.",
                    "initial": "A.L.",
                    "last": "Reingold"
                }
            ],
            "doi": "10.1136/bmj.i5170",
            "issn": "09598146",
            "pmid": "27737834",
            "pub_year": 2016,
            "title": "Association of BCG, DTP, and measles containing vaccines with childhood mortality: Systematic review",
            "volume": "355"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Morabia"
                }
            ],
            "doi": "10.1177/0141076818783658",
            "firstpage": "255",
            "issn": "01410768",
            "lastpage": "257",
            "pmid": "29978749",
            "pub_year": 2018,
            "title": "Edward Jenner\u2019s 1798 report of challenge experiments demonstrating the protective effects of cowpox against smallpox",
            "volume": "111"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Corinne Sc",
                    "initial": "C.S.",
                    "last": "Merle"
                },
                {
                    "first": "Sergio S.",
                    "initial": "S.S.",
                    "last": "Cunha"
                },
                {
                    "first": "Laura C.",
                    "initial": "L.C.",
                    "last": "Rodrigues"
                }
            ],
            "doi": "10.1586/erv.09.161",
            "firstpage": "209",
            "issn": "14760584",
            "lastpage": "222",
            "pmid": "20109030",
            "pub_year": 2010,
            "title": "BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control",
            "volume": "9"
        },
        "b0025": null,
        "b0030": {
            "authors": [
                {
                    "first": "Hope L.",
                    "initial": "H.L.",
                    "last": "Johnson"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Deloria-Knoll"
                },
                {
                    "first": "Orin S.",
                    "initial": "O.S.",
                    "last": "Levine"
                },
                {
                    "first": "Sonia K.",
                    "initial": "S.K.",
                    "last": "Stoszek"
                },
                {
                    "first": "Laura Freimanis",
                    "initial": "L.F.",
                    "last": "Hance"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Reithinger"
                },
                {
                    "first": "Larry R.",
                    "initial": "L.R.",
                    "last": "Muenz"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                }
            ],
            "doi": "10.1371/journal.pmed.1000348",
            "issn": "15491277",
            "pmid": "20957191",
            "pub_year": 2010,
            "title": "Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The pneumococcal global serotype project",
            "volume": "7"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                },
                {
                    "first": "Tamar",
                    "initial": "T.",
                    "last": "Pilishvili"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "Farley"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Schaffner"
                },
                {
                    "first": "Allen S.",
                    "initial": "A.S.",
                    "last": "Craig"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Lynfield"
                },
                {
                    "first": "Ann Christine",
                    "initial": "A.C.",
                    "last": "Nyquist"
                },
                {
                    "first": "Kenneth A.",
                    "initial": "K.A.",
                    "last": "Gershman"
                },
                {
                    "first": "Marietta",
                    "initial": "M.",
                    "last": "Vazquez"
                },
                {
                    "first": "Nancy M.",
                    "initial": "N.M.",
                    "last": "Bennett"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Reingold"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Thomas"
                },
                {
                    "first": "Mary P.",
                    "initial": "M.P.",
                    "last": "Glode"
                },
                {
                    "first": "Elizabeth R.",
                    "initial": "E.R.",
                    "last": "Zell"
                },
                {
                    "first": "James H.",
                    "initial": "J.H.",
                    "last": "Jorgensen"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Beall"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Schuchat"
                }
            ],
            "doi": "10.1016/S0140-6736(06)69637-2",
            "firstpage": "1495",
            "issn": "01406736",
            "lastpage": "1502",
            "pmid": "17071283",
            "pub_year": 2006,
            "title": "Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study",
            "volume": "368"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Carla Magda Allan S.",
                    "initial": "C.M.A.S.",
                    "last": "Domingues"
                },
                {
                    "first": "Jennifer R.",
                    "initial": "J.R.",
                    "last": "Verani"
                },
                {
                    "first": "Ernesto Issac",
                    "initial": "E.I.",
                    "last": "Montenegro Renoiner"
                },
                {
                    "first": "Maria Cristina",
                    "initial": "M.C.",
                    "last": "de Cunto Brandileone"
                },
                {
                    "first": "Brendan",
                    "initial": "B.",
                    "last": "Flannery"
                },
                {
                    "first": "Lucia Helena",
                    "initial": "L.H.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Jo\u00e3o Barberino",
                    "initial": "J.B.",
                    "last": "Santos"
                },
                {
                    "first": "Jos\u00e9 C\u00e1ssio",
                    "initial": "J.C.",
                    "last": "de Moraes"
                },
                {
                    "first": "Regina Coeli Magalh\u00e3es",
                    "initial": "R.C.M.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Marluce Aparecida Assun\u00e7\u00e3o",
                    "initial": "M.A.A.",
                    "last": "Oliveira"
                },
                {
                    "first": "Tani Maria Schilling",
                    "initial": "T.M.S.",
                    "last": "Ranieri"
                },
                {
                    "first": "Gladys Maria",
                    "initial": "G.M.",
                    "last": "Zubaran"
                },
                {
                    "first": "Ana L\u00eddia Lima",
                    "initial": "A.L.L.",
                    "last": "Solon"
                },
                {
                    "first": "Maria Iracema",
                    "initial": "M.I.",
                    "last": "de Aguiar Patr\u00edcio"
                },
                {
                    "first": "Maria Elisa Paula",
                    "initial": "M.E.P.",
                    "last": "de Oliveira"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "de C\u00e1ssia Vilasboas Silva"
                },
                {
                    "first": "Marlene Sera",
                    "initial": "M.S.",
                    "last": "Wille"
                },
                {
                    "first": "Pilar Gomes",
                    "initial": "P.G.",
                    "last": "Martinez"
                },
                {
                    "first": "Helena Keico",
                    "initial": "H.K.",
                    "last": "Sato"
                },
                {
                    "first": "Maria Cristina Hereny",
                    "initial": "M.C.H.",
                    "last": "Bordim"
                },
                {
                    "first": "Luzia Auxiliadora",
                    "initial": "L.A.",
                    "last": "Careli"
                },
                {
                    "first": "Vera L\u00facia",
                    "initial": "V.L.",
                    "last": "da Gl\u00f3ria Malheiros"
                },
                {
                    "first": "Zenize Rocha",
                    "initial": "Z.R.",
                    "last": "da Silva Costa"
                },
                {
                    "first": "Maria Goretti Varej\u00e3o",
                    "initial": "M.G.V.",
                    "last": "da Silva"
                },
                {
                    "first": "Cleidiane Santos",
                    "initial": "C.S.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Ataiza C\u00e9sar",
                    "initial": "A.C.",
                    "last": "Vieira"
                },
                {
                    "first": "Lucila Tacac\u00f4",
                    "initial": "L.T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Glaucia Gama Rahal",
                    "initial": "G.G.R.",
                    "last": "Aires"
                },
                {
                    "first": "Robmary Matias",
                    "initial": "R.M.",
                    "last": "de Almeida"
                },
                {
                    "first": "Diana Felicia",
                    "initial": "D.F.",
                    "last": "de Ara\u00fajo Margarido"
                },
                {
                    "first": "Ana L\u00facia Stone",
                    "initial": "A.L.S.",
                    "last": "de Souza"
                },
                {
                    "first": "Samanta C.G.",
                    "initial": "S.C.G.",
                    "last": "Almeida"
                },
                {
                    "first": "Angela P.",
                    "initial": "A.P.",
                    "last": "Brand\u00e3o"
                },
                {
                    "first": "Lincoln S.",
                    "initial": "L.S.",
                    "last": "Prado"
                },
                {
                    "first": "Maria Luiza L.S.",
                    "initial": "M.L.L.S.",
                    "last": "Guerra"
                },
                {
                    "first": "Orlando Cesar",
                    "initial": "O.C.",
                    "last": "Mantese"
                },
                {
                    "first": "Eitan",
                    "initial": "E.",
                    "last": "Berezin"
                },
                {
                    "first": "Cicero",
                    "initial": "C.",
                    "last": "Dias"
                },
                {
                    "first": "Cristiana",
                    "initial": "C.",
                    "last": "Nascimento"
                },
                {
                    "first": "Joice",
                    "initial": "J.",
                    "last": "Reis"
                },
                {
                    "first": "Ana Lucia",
                    "initial": "A.L.",
                    "last": "Andrade"
                },
                {
                    "first": "Solange",
                    "initial": "S.",
                    "last": "Andrade"
                },
                {
                    "first": "Flavia",
                    "initial": "F.",
                    "last": "Lobo"
                },
                {
                    "first": "Camile",
                    "initial": "C.",
                    "last": "de Moraes"
                },
                {
                    "first": "Eliane Castro",
                    "initial": "E.C.",
                    "last": "de Barros"
                },
                {
                    "first": "M\u00e1rcia Lopes",
                    "initial": "M.L.",
                    "last": "de Carvalho"
                },
                {
                    "first": "Elias Duarte Gon\u00e7alves",
                    "initial": "E.D.G.",
                    "last": "Correia"
                },
                {
                    "first": "Selma Lina",
                    "initial": "S.L.",
                    "last": "Suzuki"
                }
            ],
            "doi": "10.1016/S2213-2600(14)70060-8",
            "firstpage": "464",
            "issn": "22132600",
            "lastpage": "471",
            "pmid": "24726406",
            "pub_year": 2014,
            "title": "Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: A matched case-control study",
            "volume": "2"
        },
        "b0045": {
            "authors": [
                {
                    "first": "\u00c1ngela",
                    "initial": "\u00c1.",
                    "last": "Dom\u00ednguez"
                },
                {
                    "first": "Pilar",
                    "initial": "P.",
                    "last": "Ciruela"
                },
                {
                    "first": "Sergi",
                    "initial": "S.",
                    "last": "Hern\u00e1ndez"
                },
                {
                    "first": "Juan Jos\u00e9",
                    "initial": "J.J.",
                    "last": "Garc\u00eda-Garc\u00eda"
                },
                {
                    "first": "N\u00faria",
                    "initial": "N.",
                    "last": "Soldevila"
                },
                {
                    "first": "Conchita",
                    "initial": "C.",
                    "last": "Izquierdo"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Moraga-Llop"
                },
                {
                    "first": "Alvaro",
                    "initial": "A.",
                    "last": "D\u00edaz"
                },
                {
                    "first": "Mariona F.",
                    "initial": "M.F.",
                    "last": "De Sevilla"
                },
                {
                    "first": "Sebasti\u00e0",
                    "initial": "S.",
                    "last": "Gonz\u00e1lez-Peris"
                },
                {
                    "first": "Magda",
                    "initial": "M.",
                    "last": "Campins"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Uriona"
                },
                {
                    "first": "Johanna",
                    "initial": "J.",
                    "last": "Mart\u00ednez-Osorio"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Sol\u00e9-Ribalta"
                },
                {
                    "first": "Gemma",
                    "initial": "G.",
                    "last": "Codina"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Esteva"
                },
                {
                    "first": "Ana Mar\u00eda",
                    "initial": "A.M.",
                    "last": "Planes"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Mu\u00f1oz-Almagro"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Salleras"
                }
            ],
            "doi": "10.1371/journal.pone.0183191",
            "issn": "19326203",
            "pmid": "28806737",
            "pub_year": 2017,
            "title": "Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study",
            "volume": "12"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Germaine",
                    "initial": "G.",
                    "last": "Hanquet"
                },
                {
                    "first": "Tinne",
                    "initial": "T.",
                    "last": "Lernout"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Vergison"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Verhaegen"
                },
                {
                    "first": "Esther",
                    "initial": "E.",
                    "last": "Kissling"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Tuerlinckx"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Malfroot"
                },
                {
                    "first": "B\u00e9atrice",
                    "initial": "B.",
                    "last": "Swennen"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Sabbe"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.02.016",
            "firstpage": "2856",
            "issn": "0264410X",
            "lastpage": "2864",
            "pmid": "21342667",
            "pub_year": 2011,
            "title": "Impact of conjugate 7-valent vaccination in Belgium: Addressing methodological challenges",
            "volume": "29"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Zitta B.",
                    "initial": "Z.B.",
                    "last": "Harboe"
                },
                {
                    "first": "Palle",
                    "initial": "P.",
                    "last": "Valentiner-Branth"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Benfield"
                },
                {
                    "first": "Jens J\u00f8rgen",
                    "initial": "J.J.",
                    "last": "Christensen"
                },
                {
                    "first": "Peter H.",
                    "initial": "P.H.",
                    "last": "Andersen"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Howitz"
                },
                {
                    "first": "Karen A.",
                    "initial": "K.A.",
                    "last": "Krogfelt"
                },
                {
                    "first": "Lotte",
                    "initial": "L.",
                    "last": "Lambertsen"
                },
                {
                    "first": "Helle B.",
                    "initial": "H.B.",
                    "last": "Konradsen"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.01.017",
            "firstpage": "2642",
            "issn": "0264410X",
            "lastpage": "2647",
            "pmid": "20096392",
            "pub_year": 2010,
            "title": "Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme",
            "volume": "28"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Didrik F.",
                    "initial": "D.F.",
                    "last": "Vestrheim"
                },
                {
                    "first": "E. Arne",
                    "initial": "E.A.",
                    "last": "H\u00f8iby"
                },
                {
                    "first": "Marianne R.",
                    "initial": "M.R.",
                    "last": "Bergsaker"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "R\u00f8nning"
                },
                {
                    "first": "Ingeborg S.",
                    "initial": "I.S.",
                    "last": "Aaberge"
                },
                {
                    "first": "Dominique A.",
                    "initial": "D.A.",
                    "last": "Caugant"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.12.054",
            "firstpage": "2214",
            "issn": "0264410X",
            "lastpage": "2221",
            "pmid": "20056192",
            "pub_year": 2010,
            "title": "Indirect effect of conjugate pneumococcal vaccination in a 2 + 1 dose schedule",
            "volume": "28"
        },
        "b0065": {
            "authors": [
                {
                    "first": "In H.",
                    "initial": "I.H.",
                    "last": "Park"
                },
                {
                    "first": "Matthew R.",
                    "initial": "M.R.",
                    "last": "Moore"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Stephen I.",
                    "initial": "S.I.",
                    "last": "Pelton"
                },
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Pilishvili"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Beall"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Shelly"
                },
                {
                    "first": "Barbara E.",
                    "initial": "B.E.",
                    "last": "Mahon"
                },
                {
                    "first": "Moon H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                }
            ],
            "doi": "10.1086/593339",
            "firstpage": "1818",
            "issn": "00221899",
            "lastpage": "1822",
            "pmid": "18983249",
            "pub_year": 2008,
            "title": "Differential effects of pneumococcal vaccines against serotypes 6A and 6C",
            "volume": "198"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Genevi\u00e8ve",
                    "initial": "G.",
                    "last": "Deceuninck"
                },
                {
                    "first": "Gaston",
                    "initial": "G.",
                    "last": "De Serres"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Boulianne"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Lefebvre"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Wals"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.005",
            "firstpage": "2684",
            "issn": "0264410X",
            "lastpage": "2689",
            "pmid": "25887086",
            "pub_year": 2015,
            "title": "Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada",
            "volume": "33"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Jukka",
                    "initial": "J.",
                    "last": "Jokinen"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Rinta-Kokko"
                },
                {
                    "first": "Lotta",
                    "initial": "L.",
                    "last": "Siira"
                },
                {
                    "first": "Arto A.",
                    "initial": "A.A.",
                    "last": "Palmu"
                },
                {
                    "first": "Mikko J.",
                    "initial": "M.J.",
                    "last": "Virtanen"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Nohynek"
                },
                {
                    "first": "Anni",
                    "initial": "A.",
                    "last": "Virolainen-Julkunen"
                },
                {
                    "first": "Maija",
                    "initial": "M.",
                    "last": "Toropainen"
                },
                {
                    "first": "J. Pekka",
                    "initial": "J.P.",
                    "last": "Nuorti"
                }
            ],
            "doi": "10.1371/journal.pone.0120290",
            "issn": "19326203",
            "pmid": "25781031",
            "pub_year": 2015,
            "title": "Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children - A population-based study",
            "volume": "10"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Carl",
                    "initial": "C.",
                    "last": "Frasch"
                },
                {
                    "first": "Anu",
                    "initial": "A.",
                    "last": "Nurkka"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Ralph",
                    "initial": "R.",
                    "last": "Biemans"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1128/CVI.00402-10",
            "firstpage": "327",
            "issn": "15566811",
            "lastpage": "336",
            "pmid": "21123523",
            "pub_year": 2011,
            "title": "Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines",
            "volume": "18"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Han Wool",
                    "initial": "H.W.",
                    "last": "Kim"
                },
                {
                    "first": "Soyoung",
                    "initial": "S.",
                    "last": "Lee"
                },
                {
                    "first": "Kyung Hyo",
                    "initial": "K.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1097/MD.0000000000004854",
            "issn": "00257974",
            "pmid": "27631247",
            "pub_year": 2016,
            "title": "Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D",
            "volume": "95"
        },
        "b0090": {
            "authors": [
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Doorbar"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Quint"
                },
                {
                    "first": "Lawrence",
                    "initial": "L.",
                    "last": "Banks"
                },
                {
                    "first": "Ignacio G.",
                    "initial": "I.G.",
                    "last": "Bravo"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Stoler"
                },
                {
                    "first": "Tom R.",
                    "initial": "T.R.",
                    "last": "Broker"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Stanley"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.06.083",
            "firstpage": "F55",
            "issn": "0264410X",
            "lastpage": "F70",
            "pub_year": 2012,
            "title": "The biology and life-cycle of human papillomaviruses",
            "volume": "30"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Clifford"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Franceschi"
                },
                {
                    "first": "Mireia",
                    "initial": "M.",
                    "last": "Diaz"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Luisa Lina",
                    "initial": "L.L.",
                    "last": "Villa"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.05.026",
            "firstpage": "S26",
            "issn": "0264410X",
            "lastpage": "S34",
            "pmid": "16950015",
            "pub_year": 2006,
            "title": "Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases",
            "volume": "24"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Douglas M.",
                    "initial": "D.M.",
                    "last": "Herrin"
                },
                {
                    "first": "Emily E.",
                    "initial": "E.E.",
                    "last": "Coates"
                },
                {
                    "first": "Pamela J.",
                    "initial": "P.J.",
                    "last": "Costner"
                },
                {
                    "first": "Troy J.",
                    "initial": "T.J.",
                    "last": "Kemp"
                },
                {
                    "first": "Martha C.",
                    "initial": "M.C.",
                    "last": "Nason"
                },
                {
                    "first": "Kapil K.",
                    "initial": "K.K.",
                    "last": "Saharia"
                },
                {
                    "first": "Yuanji",
                    "initial": "Y.",
                    "last": "Pan"
                },
                {
                    "first": "Uzma N.",
                    "initial": "U.N.",
                    "last": "Sarwar"
                },
                {
                    "first": "Lasonji",
                    "initial": "L.",
                    "last": "Holman"
                },
                {
                    "first": "Galina",
                    "initial": "G.",
                    "last": "Yamshchikov"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Yuk Ying S.",
                    "initial": "Y.Y.S.",
                    "last": "Pang"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                },
                {
                    "first": "John T.",
                    "initial": "J.T.",
                    "last": "Schiller"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Ligia A.",
                    "initial": "L.A.",
                    "last": "Pinto"
                },
                {
                    "first": "Julie E.",
                    "initial": "J.E.",
                    "last": "Ledgerwood"
                }
            ],
            "doi": "10.4161/hv.34408",
            "firstpage": "3446",
            "issn": "21645515",
            "lastpage": "3454",
            "pmid": "25483691",
            "pub_year": 2014,
            "title": "Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus",
            "volume": "10"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Sara L.",
                    "initial": "S.L.",
                    "last": "Bissett"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Godi"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jit"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Beddows"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.06.028",
            "firstpage": "3922",
            "issn": "0264410X",
            "lastpage": "3929",
            "pmid": "28633892",
            "pub_year": 2017,
            "title": "Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis",
            "volume": "35"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Matti",
                    "initial": "M.",
                    "last": "Lehtinen"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Unnop",
                    "initial": "U.",
                    "last": "Jaisamrarn"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "S. Rachel",
                    "initial": "S.R.",
                    "last": "Skinner"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Apter"
                },
                {
                    "first": "Paulo",
                    "initial": "P.",
                    "last": "Naud"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Salmer\u00f3n"
                },
                {
                    "first": "Song Nan",
                    "initial": "S.N.",
                    "last": "Chow"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Kitchener"
                },
                {
                    "first": "J\u00falio C.",
                    "initial": "J.C.",
                    "last": "Teixeira"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Hedrick"
                },
                {
                    "first": "Genara",
                    "initial": "G.",
                    "last": "Limson"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Szarewski"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Romanowski"
                },
                {
                    "first": "Fred Y.",
                    "initial": "F.Y.",
                    "last": "Aoki"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Willy A.J.",
                    "initial": "W.A.J.",
                    "last": "Poppe"
                },
                {
                    "first": "Newton S.",
                    "initial": "N.S.",
                    "last": "De Carvalho"
                },
                {
                    "first": "Maria Julieta V.",
                    "initial": "M.J.V.",
                    "last": "Germar"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Peters"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Mindel"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Sutter"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Marie Pierre",
                    "initial": "M.P.",
                    "last": "David"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Struyf"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Dubin"
                }
            ],
            "doi": "10.1016/S1470-2045(11)70286-8",
            "firstpage": "89",
            "issn": "14702045",
            "lastpage": "99",
            "pmid": "22075171",
            "pub_year": 2012,
            "title": "Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial",
            "volume": "13"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Kimberley",
                    "initial": "K.",
                    "last": "Kavanagh"
                },
                {
                    "first": "Kevin G.",
                    "initial": "K.G.",
                    "last": "Pollock"
                },
                {
                    "first": "Kate",
                    "initial": "K.",
                    "last": "Cuschieri"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Palmer"
                },
                {
                    "first": "Ross L.",
                    "initial": "R.L.",
                    "last": "Cameron"
                },
                {
                    "first": "Cameron",
                    "initial": "C.",
                    "last": "Watt"
                },
                {
                    "first": "Ramya",
                    "initial": "R.",
                    "last": "Bhatia"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Moore"
                },
                {
                    "first": "Heather",
                    "initial": "H.",
                    "last": "Cubie"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Cruickshank"
                },
                {
                    "first": "Chris",
                    "initial": "C.",
                    "last": "Robertson"
                }
            ],
            "doi": "10.1016/S1473-3099(17)30468-1",
            "firstpage": "1293",
            "issn": "14733099",
            "lastpage": "1302",
            "pmid": "28965955",
            "pub_year": 2017,
            "title": "Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study",
            "volume": "17"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Szarewski"
                },
                {
                    "first": "S. Rachel",
                    "initial": "S.R.",
                    "last": "Skinner"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Romanowski"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Apter"
                },
                {
                    "first": "Song Nan",
                    "initial": "S.N.",
                    "last": "Chow"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "M. Rowena",
                    "initial": "M.R.",
                    "last": "Del Rosario-Raymundo"
                },
                {
                    "first": "Julio C.",
                    "initial": "J.C.",
                    "last": "Teixeira"
                },
                {
                    "first": "Newton S.",
                    "initial": "N.S.",
                    "last": "De Carvalho"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Castro-Sanchez"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Willy A.J.",
                    "initial": "W.A.J.",
                    "last": "Poppe"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Sutter"
                },
                {
                    "first": "Warner",
                    "initial": "W.",
                    "last": "Huh"
                },
                {
                    "first": "Archana",
                    "initial": "A.",
                    "last": "Chatterjee"
                },
                {
                    "first": "Wiebren A.",
                    "initial": "W.A.",
                    "last": "Tjalma"
                },
                {
                    "first": "Ronald T.",
                    "initial": "R.T.",
                    "last": "Ackerman"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Martens"
                },
                {
                    "first": "Kim A.",
                    "initial": "K.A.",
                    "last": "Papp"
                },
                {
                    "first": "Jose",
                    "initial": "J.",
                    "last": "Bajo-Arenas"
                },
                {
                    "first": "Diane M.",
                    "initial": "D.M.",
                    "last": "Harper"
                },
                {
                    "first": "Aureli",
                    "initial": "A.",
                    "last": "Torn\u00e9"
                },
                {
                    "first": "Marie Pierre",
                    "initial": "M.P.",
                    "last": "David"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Struyf"
                },
                {
                    "first": "Matti",
                    "initial": "M.",
                    "last": "Lehtinen"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Dubin"
                }
            ],
            "doi": "10.1093/infdis/jit360",
            "firstpage": "1391",
            "issn": "00221899",
            "lastpage": "1396",
            "pmid": "24092907",
            "pub_year": 2013,
            "title": "Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA Randomized Trial): An unexpected observation",
            "volume": "208"
        },
        "b0125": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Canvin"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sinka"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Hughes"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Mesher"
                }
            ],
            "doi": "10.1136/sextrans-2016-052626",
            "firstpage": "125",
            "issn": "13684973",
            "lastpage": "128",
            "pmid": "27365492",
            "pub_year": 2017,
            "title": "Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: An ecological analysis",
            "volume": "93"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Darron R.",
                    "initial": "D.R.",
                    "last": "Brown"
                },
                {
                    "first": "Susanne K.",
                    "initial": "S.K.",
                    "last": "Kjaer"
                },
                {
                    "first": "Kristj\u00e1n",
                    "initial": "K.",
                    "last": "Sigurdsson"
                },
                {
                    "first": "Ole Erik",
                    "initial": "O.E.",
                    "last": "Iversen"
                },
                {
                    "first": "Hernandez Avila",
                    "initial": "H.A.",
                    "last": "Mauricio"
                },
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Gonzalo",
                    "initial": "G.",
                    "last": "Perez"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Koutsky"
                },
                {
                    "first": "Eng Hseon",
                    "initial": "E.H.",
                    "last": "Tay"
                },
                {
                    "first": "Patric\u00eda",
                    "initial": "P.",
                    "last": "Garcia"
                },
                {
                    "first": "Kevin A.",
                    "initial": "K.A.",
                    "last": "Ault"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Sepp",
                    "initial": "S.",
                    "last": "Leodolter"
                },
                {
                    "first": "Sven Eric",
                    "initial": "S.E.",
                    "last": "Olsson"
                },
                {
                    "first": "Grace W.K.",
                    "initial": "G.W.K.",
                    "last": "Tang"
                },
                {
                    "first": "Daron G.",
                    "initial": "D.G.",
                    "last": "Ferris"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Steben"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Joakim",
                    "initial": "J.",
                    "last": "Dillner"
                },
                {
                    "first": "Elmar A.",
                    "initial": "E.A.",
                    "last": "Joura"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Kurman"
                },
                {
                    "first": "Slawomir",
                    "initial": "S.",
                    "last": "Majewski"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Evan R.",
                    "initial": "E.R.",
                    "last": "Myers"
                },
                {
                    "first": "Luisa L.",
                    "initial": "L.L.",
                    "last": "Villa"
                },
                {
                    "first": "Frank J.",
                    "initial": "F.J.",
                    "last": "Taddeo"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Roberts"
                },
                {
                    "first": "Amha",
                    "initial": "A.",
                    "last": "Tadesse"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Bryan"
                },
                {
                    "first": "Lisa C.",
                    "initial": "L.C.",
                    "last": "Lupinacci"
                },
                {
                    "first": "Katherine E.D.",
                    "initial": "K.E.D.",
                    "last": "Giacoletti"
                },
                {
                    "first": "Heather L.",
                    "initial": "H.L.",
                    "last": "Sings"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "James"
                },
                {
                    "first": "Teresa M.",
                    "initial": "T.M.",
                    "last": "Hesley"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barra"
                }
            ],
            "doi": "10.1086/597307",
            "firstpage": "926",
            "issn": "00221899",
            "lastpage": "935",
            "pmid": "19236279",
            "pub_year": 2009,
            "title": "The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years",
            "volume": "199"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Susanne K.",
                    "initial": "S.K.",
                    "last": "Kjaer"
                },
                {
                    "first": "Kristj\u00e1n",
                    "initial": "K.",
                    "last": "Sigurdsson"
                },
                {
                    "first": "Ole Erik",
                    "initial": "O.E.",
                    "last": "Iversen"
                },
                {
                    "first": "Hernandez Avila",
                    "initial": "H.A.",
                    "last": "Mauricio"
                },
                {
                    "first": "Gonzalo",
                    "initial": "G.",
                    "last": "Perez"
                },
                {
                    "first": "Darron R.",
                    "initial": "D.R.",
                    "last": "Brown"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Koutsky"
                },
                {
                    "first": "Eng Hseon",
                    "initial": "E.H.",
                    "last": "Tay"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Garc\u00eda"
                },
                {
                    "first": "Kevin A.",
                    "initial": "K.A.",
                    "last": "Ault"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Sepp",
                    "initial": "S.",
                    "last": "Leodolter"
                },
                {
                    "first": "Sven Eric",
                    "initial": "S.E.",
                    "last": "Olsson"
                },
                {
                    "first": "Grace W.K.",
                    "initial": "G.W.K.",
                    "last": "Tang"
                },
                {
                    "first": "Daron G.",
                    "initial": "D.G.",
                    "last": "Ferris"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Steben"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Joakim",
                    "initial": "J.",
                    "last": "Dillner"
                },
                {
                    "first": "Elmar A.",
                    "initial": "E.A.",
                    "last": "Joura"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Kurman"
                },
                {
                    "first": "Slawomir",
                    "initial": "S.",
                    "last": "Majewski"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Evan R.",
                    "initial": "E.R.",
                    "last": "Myers"
                },
                {
                    "first": "Luisa L.",
                    "initial": "L.L.",
                    "last": "Villa"
                },
                {
                    "first": "Frank J.",
                    "initial": "F.J.",
                    "last": "Taddeo"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Roberts"
                },
                {
                    "first": "Amha",
                    "initial": "A.",
                    "last": "Tadesse"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Bryan"
                },
                {
                    "first": "Lisa C.",
                    "initial": "L.C.",
                    "last": "Lupinacci"
                },
                {
                    "first": "Katherine E.D.",
                    "initial": "K.E.D.",
                    "last": "Giacoletti"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "James"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Vuocolo"
                },
                {
                    "first": "Teresa M.",
                    "initial": "T.M.",
                    "last": "Hesley"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barra"
                }
            ],
            "doi": "10.1086/597309",
            "firstpage": "936",
            "issn": "00221899",
            "lastpage": "944",
            "pmid": "19236277",
            "pub_year": 2009,
            "title": "The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine hpv types in sexually active women aged 16-26 years",
            "volume": "199"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Berit",
                    "initial": "B.",
                    "last": "Feiring"
                },
                {
                    "first": "Ida",
                    "initial": "I.",
                    "last": "Laake"
                },
                {
                    "first": "Irene Kraus",
                    "initial": "I.K.",
                    "last": "Christiansen"
                },
                {
                    "first": "Mona",
                    "initial": "M.",
                    "last": "Hansen"
                },
                {
                    "first": "Jeanette",
                    "initial": "J.",
                    "last": "St\u00e5lcrantz"
                },
                {
                    "first": "Ole Herman",
                    "initial": "O.H.",
                    "last": "Ambur"
                },
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Magnus"
                },
                {
                    "first": "Christine Monceyron",
                    "initial": "C.M.",
                    "last": "Jonassen"
                },
                {
                    "first": "Lill",
                    "initial": "L.",
                    "last": "Trogstad"
                }
            ],
            "doi": "10.1093/infdis/jiy432",
            "firstpage": "1900",
            "issn": "00221899",
            "lastpage": "1910",
            "pmid": "30010913",
            "pub_year": 2018,
            "title": "Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway",
            "volume": "218"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Richard B.S.",
                    "initial": "R.B.S.",
                    "last": "Roden"
                },
                {
                    "first": "Peter L.",
                    "initial": "P.L.",
                    "last": "Stern"
                }
            ],
            "doi": "10.1038/nrc.2018.13",
            "firstpage": "240",
            "issn": "1474175X",
            "lastpage": "254",
            "pmid": "29497146",
            "pub_year": 2018,
            "title": "Opportunities and challenges for human papillomavirus vaccination in cancer",
            "volume": "18"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Julia M.L.",
                    "initial": "J.M.L.",
                    "last": "Brotherton"
                },
                {
                    "first": "Paul N.",
                    "initial": "P.N.",
                    "last": "Bloem"
                }
            ],
            "doi": "10.1016/j.bpobgyn.2017.08.010",
            "firstpage": "42",
            "issn": "15216934",
            "lastpage": "58",
            "pmid": "28986092",
            "pub_year": 2018,
            "title": "Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage",
            "volume": "47"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Morel"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Lockman"
                },
                {
                    "first": "Sandra L.",
                    "initial": "S.L.",
                    "last": "Giannini"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Bisteau"
                },
                {
                    "first": "Harald",
                    "initial": "H.",
                    "last": "Carlsen"
                },
                {
                    "first": "Anders",
                    "initial": "A.",
                    "last": "Kielland"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Vosters"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Vanderheyde"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Schiavetti"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Larocque"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                }
            ],
            "doi": "10.4049/jimmunol.0901474",
            "firstpage": "6186",
            "issn": "00221767",
            "lastpage": "6197",
            "pmid": "19864596",
            "pub_year": 2009,
            "title": "AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity",
            "volume": "183"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Jelle",
                    "initial": "J.",
                    "last": "Matthijnssens"
                },
                {
                    "first": "Peter H.",
                    "initial": "P.H.",
                    "last": "Otto"
                },
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Ciarlet"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Desselberger"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "van Ranst"
                },
                {
                    "first": "Reimar",
                    "initial": "R.",
                    "last": "Johne"
                }
            ],
            "doi": "10.1007/s00705-012-1273-3",
            "firstpage": "1177",
            "issn": "03048608",
            "lastpage": "1182",
            "pmid": "22430951",
            "pub_year": 2012,
            "title": "VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation",
            "volume": "157"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Norma",
                    "initial": "N.",
                    "last": "Santos"
                },
                {
                    "first": "Yasutaka",
                    "initial": "Y.",
                    "last": "Hoshino"
                }
            ],
            "doi": "10.1002/rmv.448",
            "firstpage": "29",
            "issn": "10529276",
            "lastpage": "56",
            "pmid": "15484186",
            "pub_year": 2005,
            "title": "Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine",
            "volume": "15"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Kriszti\u00e1n",
                    "initial": "K.",
                    "last": "B\u00e1nyai"
                },
                {
                    "first": "Brigitta",
                    "initial": "B.",
                    "last": "L\u00e1szl\u00f3"
                },
                {
                    "first": "Jazmin",
                    "initial": "J.",
                    "last": "Duque"
                },
                {
                    "first": "A. Duncan",
                    "initial": "A.D.",
                    "last": "Steele"
                },
                {
                    "first": "E. Anthony S.",
                    "initial": "E.A.S.",
                    "last": "Nelson"
                },
                {
                    "first": "Jon R.",
                    "initial": "J.R.",
                    "last": "Gentsch"
                },
                {
                    "first": "Umesh D.",
                    "initial": "U.D.",
                    "last": "Parashar"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.09.111",
            "firstpage": "A122",
            "issn": "0264410X",
            "lastpage": "A130",
            "pmid": "22520121",
            "pub_year": 2012,
            "title": "Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs",
            "volume": "30"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Gray"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Carlo",
                    "initial": "C.",
                    "last": "Giaquinto"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Mrukowicz"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Guarino"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Hania",
                    "initial": "H.",
                    "last": "Szajewska"
                },
                {
                    "first": "Vytautas",
                    "initial": "V.",
                    "last": "Usonis"
                }
            ],
            "doi": "10.1097/MPG.0b013e31816f78ee",
            "firstpage": "S24",
            "issn": "02772116",
            "lastpage": "S31",
            "pmid": "18460969",
            "pub_year": 2008,
            "title": "Rotavirus",
            "volume": "46"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Penelope H.",
                    "initial": "P.H.",
                    "last": "Dennehy"
                }
            ],
            "doi": "10.1128/CMR.00029-07",
            "firstpage": "198",
            "issn": "08938512",
            "lastpage": "208",
            "pmid": "18202442",
            "pub_year": 2008,
            "title": "Rotavirus vaccines: An overview",
            "volume": "21"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Daniel E.",
                    "initial": "D.E.",
                    "last": "Velasquez"
                },
                {
                    "first": "Umesh D.",
                    "initial": "U.D.",
                    "last": "Parashar"
                },
                {
                    "first": "Baoming",
                    "initial": "B.",
                    "last": "Jiang"
                }
            ],
            "doi": "10.1016/j.meegid.2014.10.008",
            "firstpage": "561",
            "issn": "15671348",
            "lastpage": "571",
            "pmid": "25460825",
            "pub_year": 2014,
            "title": "Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: An overview",
            "volume": "28"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Takeuchi"
                }
            ],
            "doi": "10.4161/hv.28284",
            "firstpage": "1421",
            "issn": "21645515",
            "lastpage": "1424",
            "pmid": "24608099",
            "pub_year": 2014,
            "title": "Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine: A preliminary report of re-analyses of data from a Cochrane Database Systematic Review",
            "volume": "10"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Guillermo M.",
                    "initial": "G.M.",
                    "last": "Ruiz-Palacios"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "P\u00e9rez-Schael"
                },
                {
                    "first": "F. Ra\u00fal",
                    "initial": "F.R.",
                    "last": "Vel\u00e1zquez"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Abate"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Breuer"
                },
                {
                    "first": "Sue Ann Costa",
                    "initial": "S.A.C.",
                    "last": "Clemens"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Cheuvart"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Espinoza"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Gillard"
                },
                {
                    "first": "Bruce L.",
                    "initial": "B.L.",
                    "last": "Innis"
                },
                {
                    "first": "Yolanda",
                    "initial": "Y.",
                    "last": "Cervantes"
                },
                {
                    "first": "Alexandre C.",
                    "initial": "A.C.",
                    "last": "Linhares"
                },
                {
                    "first": "P\u00edo",
                    "initial": "P.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Mercedes",
                    "initial": "M.",
                    "last": "Mac\u00edas-Parra"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Vesta",
                    "initial": "V.",
                    "last": "Richardson"
                },
                {
                    "first": "Doris Maribel",
                    "initial": "D.M.",
                    "last": "Rivera-Medina"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Rivera"
                },
                {
                    "first": "Bel\u00e9n",
                    "initial": "B.",
                    "last": "Salinas"
                },
                {
                    "first": "Noris",
                    "initial": "N.",
                    "last": "Pav\u00eda-Ruz"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Salmer\u00f3n"
                },
                {
                    "first": "Ricardo",
                    "initial": "R.",
                    "last": "R\u00fcttimann"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Tinoco"
                },
                {
                    "first": "Pilar",
                    "initial": "P.",
                    "last": "Rubio"
                },
                {
                    "first": "Ernesto",
                    "initial": "E.",
                    "last": "Nu\u00f1ez"
                },
                {
                    "first": "M. Lourdes",
                    "initial": "M.L.",
                    "last": "Guerrero"
                },
                {
                    "first": "Juan Pablo",
                    "initial": "J.P.",
                    "last": "Yarz\u00e1bal"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Damaso"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Tornieporth"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Rodrigo F.",
                    "initial": "R.F.",
                    "last": "Vergara"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Clemens"
                },
                {
                    "first": "B\u00e9atrice",
                    "initial": "B.",
                    "last": "De Vos"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "O'Ryan"
                }
            ],
            "doi": "10.1056/NEJMoa052434",
            "firstpage": "11",
            "issn": "00284793",
            "lastpage": "22",
            "pmid": "16394298",
            "pub_year": 2006,
            "title": "Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis",
            "volume": "354"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Alexandre C.",
                    "initial": "A.C.",
                    "last": "Linhares"
                },
                {
                    "first": "F. Ra\u00fal",
                    "initial": "F.R.",
                    "last": "Vel\u00e1zquez"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "P\u00e9rez-Schael"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Abate"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Espinoza"
                },
                {
                    "first": "P\u00edo",
                    "initial": "P.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Mercedes",
                    "initial": "M.",
                    "last": "Mac\u00edas-Parra"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Doris Maribel",
                    "initial": "D.M.",
                    "last": "Rivera-Medina"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Rivera"
                },
                {
                    "first": "Noris",
                    "initial": "N.",
                    "last": "Pav\u00eda-Ruz"
                },
                {
                    "first": "Ernesto",
                    "initial": "E.",
                    "last": "Nu\u00f1ez"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Damaso"
                },
                {
                    "first": "Guillermo M.",
                    "initial": "G.M.",
                    "last": "Ruiz-Palacios"
                },
                {
                    "first": "B\u00e9atrice",
                    "initial": "B.",
                    "last": "De Vos"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "O'Ryan"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Gillard"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                }
            ],
            "doi": "10.1016/S0140-6736(08)60524-3",
            "firstpage": "1181",
            "issn": "01406736",
            "lastpage": "1189",
            "pmid": "18395579",
            "pub_year": 2008,
            "title": "Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study",
            "volume": "371"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Nigel A.",
                    "initial": "N.A.",
                    "last": "Cunliffe"
                },
                {
                    "first": "Duncan",
                    "initial": "D.",
                    "last": "Steele"
                },
                {
                    "first": "Desir\u00e9e",
                    "initial": "D.",
                    "last": "Witte"
                },
                {
                    "first": "Mari",
                    "initial": "M.",
                    "last": "Kirsten"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Louw"
                },
                {
                    "first": "Bagrey",
                    "initial": "B.",
                    "last": "Ngwira"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "Victor"
                },
                {
                    "first": "Paul H.",
                    "initial": "P.H.",
                    "last": "Gillard"
                },
                {
                    "first": "Brigitte B.",
                    "initial": "B.B.",
                    "last": "Cheuvart"
                },
                {
                    "first": "Htay H.",
                    "initial": "H.H.",
                    "last": "Han"
                },
                {
                    "first": "Kathleen M.",
                    "initial": "K.M.",
                    "last": "Neuzil"
                }
            ],
            "doi": "10.1056/NEJMoa0904797",
            "firstpage": "289",
            "issn": "00284793",
            "lastpage": "298",
            "pub_year": 2010,
            "title": "Effect of human rotavirus vaccine on severe diarrhea in African infants",
            "volume": "362"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Andrew D.",
                    "initial": "A.D.",
                    "last": "Steele"
                },
                {
                    "first": "Kathleen M.",
                    "initial": "K.M.",
                    "last": "Neuzil"
                },
                {
                    "first": "Nigel A.",
                    "initial": "N.A.",
                    "last": "Cunliffe"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Pieter",
                    "initial": "P.",
                    "last": "Bos"
                },
                {
                    "first": "Bagrey",
                    "initial": "B.",
                    "last": "Ngwira"
                },
                {
                    "first": "Desiree",
                    "initial": "D.",
                    "last": "Witte"
                },
                {
                    "first": "Stacy",
                    "initial": "S.",
                    "last": "Todd"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Louw"
                },
                {
                    "first": "Mari",
                    "initial": "M.",
                    "last": "Kirsten"
                },
                {
                    "first": "Sanet",
                    "initial": "S.",
                    "last": "Aspinall"
                },
                {
                    "first": "Leen J.",
                    "initial": "L.J.",
                    "last": "Van Doorn"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                },
                {
                    "first": "Pemmaraju V.",
                    "initial": "P.V.",
                    "last": "Suryakiran"
                },
                {
                    "first": "Htay H.",
                    "initial": "H.H.",
                    "last": "Han"
                }
            ],
            "doi": "10.1186/1471-2334-12-213",
            "issn": "14712334",
            "pmid": "22974466",
            "pub_year": 2012,
            "title": "Human rotavirus vaccine Rotarix\u2122 provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial",
            "volume": "12"
        },
        "b0215": {
            "authors": [
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Karvonen"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Schuster"
                },
                {
                    "first": "JC",
                    "initial": "J.",
                    "last": "Tejedor"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Cohen"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Meurice"
                },
                {
                    "first": "HH",
                    "initial": "H.",
                    "last": "Han"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Damaso"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                }
            ],
            "doi": "10.1016/S0140-6736(07)61744-9",
            "firstpage": "1757",
            "issn": "01406736",
            "lastpage": "1763",
            "pmid": "18037080",
            "pub_year": 2007,
            "title": "Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study",
            "volume": "370"
        },
        "b0220": {
            "authors": [
                {
                    "first": "K. B.",
                    "initial": "K.B.",
                    "last": "Phua"
                },
                {
                    "first": "F. S.",
                    "initial": "F.S.",
                    "last": "Lim"
                },
                {
                    "first": "Y. L.",
                    "initial": "Y.L.",
                    "last": "Lau"
                },
                {
                    "first": "E. A.S.",
                    "initial": "E.A.S.",
                    "last": "Nelson"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Huang"
                },
                {
                    "first": "S. H.",
                    "initial": "S.H.",
                    "last": "Quak"
                },
                {
                    "first": "B. W.",
                    "initial": "B.W.",
                    "last": "Lee"
                },
                {
                    "first": "Y. L.",
                    "initial": "Y.L.",
                    "last": "Teoh"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Tang"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Boudville"
                },
                {
                    "first": "L. C.",
                    "initial": "L.C.",
                    "last": "Oostvogels"
                },
                {
                    "first": "P. V.",
                    "initial": "P.V.",
                    "last": "Suryakiran"
                },
                {
                    "first": "I. V.",
                    "initial": "I.V.",
                    "last": "Smolenov"
                },
                {
                    "first": "H. H.",
                    "initial": "H.H.",
                    "last": "Han"
                },
                {
                    "first": "H. L.",
                    "initial": "H.L.",
                    "last": "Bock"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.07.098",
            "firstpage": "5936",
            "issn": "0264410X",
            "lastpage": "5941",
            "pmid": "19679216",
            "pub_year": 2009,
            "title": "Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study",
            "volume": "27"
        },
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "Tarja",
                    "initial": "T.",
                    "last": "Ruuska"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                }
            ],
            "doi": "10.3109/00365549009027046",
            "firstpage": "259",
            "issn": "00365548",
            "lastpage": "267",
            "pmid": "2371542",
            "pub_year": 1990,
            "title": "Rotavirus disease in finnish children: Use of numerical scores for clinical severity of diarrhoeal episodes",
            "volume": "22"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Davide",
                    "initial": "D.",
                    "last": "Serruto"
                },
                {
                    "first": "Matthew J.",
                    "initial": "M.J.",
                    "last": "Bottomley"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Marzia M.",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.01.033",
            "firstpage": "B87",
            "issn": "0264410X",
            "lastpage": "B97",
            "pmid": "22607904",
            "pub_year": 2012,
            "title": "The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens",
            "volume": "30"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Vipond"
                },
                {
                    "first": "Rory",
                    "initial": "R.",
                    "last": "Care"
                },
                {
                    "first": "Ian M.",
                    "initial": "I.M.",
                    "last": "Feavers"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.12.060",
            "firstpage": "B10",
            "issn": "0264410X",
            "lastpage": "B17",
            "pmid": "22607894",
            "pub_year": 2012,
            "title": "History of meningococcal vaccines and their serological correlates of protection",
            "volume": "30"
        },
        "b0245": {
            "authors": [
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Wilkins"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Snape"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.07.056",
            "firstpage": "5470",
            "issn": "0264410X",
            "lastpage": "5476",
            "pmid": "28778616",
            "pub_year": 2018,
            "title": "Emerging clinical experience with vaccines against group B meningococcal disease",
            "volume": "36"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Holst"
                },
                {
                    "first": "Philipp",
                    "initial": "P.",
                    "last": "Oster"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Arnold"
                },
                {
                    "first": "Michael V.",
                    "initial": "M.V.",
                    "last": "Tatley"
                },
                {
                    "first": "Lisbeth M.",
                    "initial": "L.M.",
                    "last": "N\u00e6ss"
                },
                {
                    "first": "Ingeborg S.",
                    "initial": "I.S.",
                    "last": "Aaberge"
                },
                {
                    "first": "Yvonne",
                    "initial": "Y.",
                    "last": "Galloway"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "McNicholas"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "O'Hallahan"
                },
                {
                    "first": "Einar",
                    "initial": "E.",
                    "last": "Rosenqvist"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Black"
                }
            ],
            "doi": "10.4161/hv.24129",
            "firstpage": "1241",
            "issn": "21645515",
            "lastpage": "1253",
            "pmid": "23857274",
            "pub_year": 2013,
            "title": "Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV) Lessons from past programs and implications for the future",
            "volume": "9"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Matt",
                    "initial": "M.",
                    "last": "Shirley"
                },
                {
                    "first": "Sohita",
                    "initial": "S.",
                    "last": "Dhillon"
                }
            ],
            "doi": "10.1007/s40259-015-0139-0",
            "firstpage": "353",
            "issn": "11738804",
            "lastpage": "361",
            "pmid": "26394633",
            "pub_year": 2015,
            "title": "Bivalent rLP2086 Vaccine (Trumenba\u00ae): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years",
            "volume": "29"
        },
        "b0260": {
            "authors": [
                {
                    "first": "Duccio",
                    "initial": "D.",
                    "last": "Medini"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Stella"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Wassil"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.015",
            "firstpage": "2629",
            "issn": "0264410X",
            "lastpage": "2636",
            "pmid": "25882169",
            "pub_year": 2015,
            "title": "MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine",
            "volume": "33"
        },
        "b0265": {
            "authors": [
                {
                    "first": "Giacomo",
                    "initial": "G.",
                    "last": "Frosi"
                },
                {
                    "first": "Alessia",
                    "initial": "A.",
                    "last": "Biolchi"
                },
                {
                    "first": "Morena Lo",
                    "initial": "M.L.",
                    "last": "Sapio"
                },
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Rigat"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Gilchrist"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Lucidarme"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Marzia Monica",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Duccio",
                    "initial": "D.",
                    "last": "Medini"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.08.006",
            "firstpage": "4968",
            "issn": "0264410X",
            "lastpage": "4974",
            "pmid": "23954380",
            "pub_year": 2013,
            "title": "Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage",
            "volume": "31"
        },
        "b0270": null,
        "b0275": null,
        "b0280": {
            "authors": [
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Hong"
                },
                {
                    "first": "Marzia Monica",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Ala Eddine",
                    "initial": "A.E.",
                    "last": "Deghmane"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Comanducci"
                },
                {
                    "first": "Brunella",
                    "initial": "B.",
                    "last": "Brunelli"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Dull"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.12.022",
            "firstpage": "1113",
            "issn": "0264410X",
            "lastpage": "1116",
            "pmid": "23261039",
            "pub_year": 2013,
            "title": "Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?",
            "volume": "31"
        },
        "b0285": {
            "authors": [
                {
                    "first": "Shamez N.",
                    "initial": "S.N.",
                    "last": "Ladhani"
                },
                {
                    "first": "Marzia Monica",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Alessia",
                    "initial": "A.",
                    "last": "Biolchi"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Kazim",
                    "initial": "K.",
                    "last": "Beebeejaun"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Lucidarme"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.3201/eid2202.150369",
            "firstpage": "309",
            "issn": "10806040",
            "lastpage": "311",
            "pmid": "26811872",
            "pub_year": 2016,
            "title": "Effectiveness of meningococcal B vaccine against endemic hypervirulent neisseria meningitidis W strain, England",
            "volume": "22"
        },
        "b0290": null,
        "b0295": {
            "authors": [
                {
                    "first": "C. R.",
                    "initial": "C.R.",
                    "last": "Tinsley"
                },
                {
                    "first": "X.",
                    "initial": "X.",
                    "last": "Nassif"
                }
            ],
            "doi": "10.1073/pnas.93.20.11109",
            "firstpage": "11109",
            "issn": "00278424",
            "lastpage": "11114",
            "pmid": "8855317",
            "pub_year": 1996,
            "title": "Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities",
            "volume": "93"
        },
        "b0300": {
            "authors": [
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Edwards"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Jennings"
                },
                {
                    "first": "Kate L.",
                    "initial": "K.L.",
                    "last": "Seib"
                }
            ],
            "doi": "10.1097/QCO.0000000000000450",
            "firstpage": "246",
            "issn": "09517375",
            "lastpage": "250",
            "pub_year": 2018,
            "title": "Neisseria gonorrhoeae vaccine development: Hope on the horizon?",
            "volume": "31"
        },
        "b0305": {
            "authors": [
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Whelan"
                },
                {
                    "first": "Hilde",
                    "initial": "H.",
                    "last": "Kl\u00f8vstad"
                },
                {
                    "first": "Inger Lise",
                    "initial": "I.L.",
                    "last": "Haugen"
                },
                {
                    "first": "Mirna",
                    "initial": "M.",
                    "last": "Robert-Du Ry van Beest Holle"
                },
                {
                    "first": "Jann",
                    "initial": "J.",
                    "last": "Storsaeter"
                }
            ],
            "doi": "10.3201/eid2206.151093",
            "firstpage": "1137",
            "issn": "10806040",
            "lastpage": "1139",
            "pmid": "27191543",
            "pub_year": 2016,
            "title": "Ecologic study of meningococcal B vaccine and Neisseria gonorrhoeae infection, Norway",
            "volume": "22"
        },
        "b0310": {
            "authors": [
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Petousis-Harris"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Paynter"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Morgan"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Saxton"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "McArdle"
                },
                {
                    "first": "Felicity",
                    "initial": "F.",
                    "last": "Goodyear-Smith"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Black"
                }
            ],
            "doi": "10.1016/S0140-6736(17)31449-6",
            "firstpage": "1603",
            "issn": "01406736",
            "lastpage": "1610",
            "pmid": "28705462",
            "pub_year": 2017,
            "title": "Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study",
            "volume": "390"
        },
        "b0315": null,
        "b0320": {
            "authors": [
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Orsi"
                },
                {
                    "first": "Filippo",
                    "initial": "F.",
                    "last": "Ansaldi"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "De Florentiis"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Ceravolo"
                },
                {
                    "first": "Valentina",
                    "initial": "V.",
                    "last": "Parodi"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Canepa"
                },
                {
                    "first": "Martina",
                    "initial": "M.",
                    "last": "Coppelli"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Icardi"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Durando"
                }
            ],
            "doi": "10.4161/hv.23239",
            "firstpage": "582",
            "issn": "21645515",
            "lastpage": "590",
            "pmid": "23295230",
            "pub_year": 2013,
            "title": "Cross-protection against drifted influenza viruses: Options offered by adjuvanted and intradermal vaccines",
            "volume": "9"
        },
        "b0325": {
            "authors": [
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Camilloni"
                },
                {
                    "first": "Michela",
                    "initial": "M.",
                    "last": "Basileo"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Valente"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Nunzi"
                },
                {
                    "first": "Anna Maria",
                    "initial": "A.M.",
                    "last": "Iorio"
                }
            ],
            "doi": "10.1080/21645515.2015.1011562",
            "firstpage": "553",
            "issn": "21645515",
            "lastpage": "563",
            "pmid": "25714138",
            "pub_year": 2015,
            "title": "Immunogenicity of intramuscular MF59- Adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review",
            "volume": "11"
        },
        "b0330": {
            "authors": [
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Domnich"
                },
                {
                    "first": "Lucia",
                    "initial": "L.",
                    "last": "Arata"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Amicizia"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "Donatella",
                    "initial": "D.",
                    "last": "Panatto"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.12.011",
            "firstpage": "513",
            "issn": "0264410X",
            "lastpage": "520",
            "pmid": "28024956",
            "pub_year": 2017,
            "title": "Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis",
            "volume": "35"
        },
        "b0335": {
            "authors": [
                {
                    "first": "Vincenzo",
                    "initial": "V.",
                    "last": "Baldo"
                },
                {
                    "first": "Tatjana",
                    "initial": "T.",
                    "last": "Baldovin"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Pellegrini"
                },
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Angiolelli"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Majori"
                },
                {
                    "first": "Annarosa",
                    "initial": "A.",
                    "last": "Floreani"
                },
                {
                    "first": "Marta Cecilia",
                    "initial": "M.C.",
                    "last": "Busana"
                },
                {
                    "first": "Chiara",
                    "initial": "C.",
                    "last": "Bertoncello"
                },
                {
                    "first": "Renzo",
                    "initial": "R.",
                    "last": "Trivello"
                }
            ],
            "doi": "10.1155/2010/517198",
            "issn": "17402522",
            "pmid": "20369059",
            "pub_year": 2010,
            "title": "Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents",
            "volume": "2010"
        },
        "b0340": {
            "authors": [
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Cowling"
                },
                {
                    "first": "Sophia",
                    "initial": "S.",
                    "last": "Ng"
                },
                {
                    "first": "Edward S.K.",
                    "initial": "E.S.K.",
                    "last": "Ma"
                },
                {
                    "first": "Vicky J.",
                    "initial": "V.J.",
                    "last": "Fang"
                },
                {
                    "first": "Hau Chi",
                    "initial": "H.C.",
                    "last": "So"
                },
                {
                    "first": "Winnie",
                    "initial": "W.",
                    "last": "Wai"
                },
                {
                    "first": "Calvin K.Y.",
                    "initial": "C.K.Y.",
                    "last": "Cheng"
                },
                {
                    "first": "Jessica Y.",
                    "initial": "J.Y.",
                    "last": "Wong"
                },
                {
                    "first": "Kwok Hung",
                    "initial": "K.H.",
                    "last": "Chan"
                },
                {
                    "first": "Dennis K.M.",
                    "initial": "D.K.M.",
                    "last": "Ip"
                },
                {
                    "first": "Susan S.",
                    "initial": "S.S.",
                    "last": "Chiu"
                },
                {
                    "first": "J. S.Malik",
                    "initial": "J.S.M.",
                    "last": "Peiris"
                },
                {
                    "first": "Gabriel M.",
                    "initial": "G.M.",
                    "last": "Leung"
                }
            ],
            "doi": "10.1093/cid/cis518",
            "firstpage": "695",
            "issn": "10584838",
            "lastpage": "702",
            "pmid": "22670050",
            "pub_year": 2012,
            "title": "Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in hong kong: A randomized controlled trial",
            "volume": "55"
        },
        "b0345": {
            "authors": [
                {
                    "first": "Kinnera E.",
                    "initial": "K.E.",
                    "last": "Chada"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Forshee"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Anderson"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Yang"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.029",
            "firstpage": "3162",
            "issn": "0264410X",
            "lastpage": "3170",
            "pmid": "28483200",
            "pub_year": 2017,
            "title": "A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines",
            "volume": "35"
        },
        "b0350": {
            "authors": [
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Astrid",
                    "initial": "A.",
                    "last": "Borkowski"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Vanwolleghem"
                },
                {
                    "first": "Mamadou",
                    "initial": "M.",
                    "last": "Dram\u00e9"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Clement"
                },
                {
                    "first": "Eliane",
                    "initial": "E.",
                    "last": "Hons"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                }
            ],
            "doi": "10.1016/S0140-6736(07)61297-5",
            "firstpage": "580",
            "issn": "01406736",
            "lastpage": "589",
            "pmid": "17707753",
            "pub_year": 2007,
            "title": "Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial",
            "volume": "370"
        },
        "b0355": {
            "authors": [
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Bernhard"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "G\u00e9rard"
                },
                {
                    "first": "Mamadou",
                    "initial": "M.",
                    "last": "Dram\u00e9"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Hanon"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                }
            ],
            "doi": "10.1371/journal.pone.0001665",
            "issn": "19326203",
            "pmid": "18301743",
            "pub_year": 2008,
            "title": "Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine",
            "volume": "3"
        },
        "b0360": {
            "authors": [
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Thomson"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Jackson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Olson"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Wang"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Liavonchanka"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Keleta"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Silva"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Diederich"
                },
                {
                    "first": "R. B.",
                    "initial": "R.B.",
                    "last": "Jones"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Gubbay"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Pasick"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Petric"
                },
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Jean"
                },
                {
                    "first": "V. G.",
                    "initial": "V.G.",
                    "last": "Allen"
                },
                {
                    "first": "E. G.",
                    "initial": "E.G.",
                    "last": "Brown"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Rini"
                },
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Schrader"
                }
            ],
            "doi": "10.3389/fimmu.2012.00087",
            "issn": "16643224",
            "pub_year": 2012,
            "title": "Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem",
            "volume": "3"
        },
        "b0365": {
            "authors": [
                {
                    "first": "Gui Mei",
                    "initial": "G.M.",
                    "last": "Li"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Chiu"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Wrammert"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "McCausland"
                },
                {
                    "first": "Sarah F.",
                    "initial": "S.F.",
                    "last": "Andrews"
                },
                {
                    "first": "Nai Ying",
                    "initial": "N.Y.",
                    "last": "Zheng"
                },
                {
                    "first": "Jane Hwei",
                    "initial": "J.H.",
                    "last": "Lee"
                },
                {
                    "first": "Min",
                    "initial": "M.",
                    "last": "Huang"
                },
                {
                    "first": "Xinyan",
                    "initial": "X.",
                    "last": "Qu"
                },
                {
                    "first": "Srilatha",
                    "initial": "S.",
                    "last": "Edupuganti"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Mulligan"
                },
                {
                    "first": "Suman R.",
                    "initial": "S.R.",
                    "last": "Das"
                },
                {
                    "first": "Jonathan W.",
                    "initial": "J.W.",
                    "last": "Yewdell"
                },
                {
                    "first": "Aneesh K.",
                    "initial": "A.K.",
                    "last": "Mehta"
                },
                {
                    "first": "Patrick C.",
                    "initial": "P.C.",
                    "last": "Wilson"
                },
                {
                    "first": "Rafi",
                    "initial": "R.",
                    "last": "Ahmed"
                }
            ],
            "doi": "10.1073/pnas.1118979109",
            "firstpage": "9047",
            "issn": "00278424",
            "lastpage": "9052",
            "pmid": "22615367",
            "pub_year": 2012,
            "title": "Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells",
            "volume": "109"
        },
        "b0370": {
            "authors": [
                {
                    "first": "Maria Dolores",
                    "initial": "M.D.",
                    "last": "Fernandez-Garcia"
                },
                {
                    "first": "Michela",
                    "initial": "M.",
                    "last": "Mazzon"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Jacobs"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Amara"
                }
            ],
            "doi": "10.1016/j.chom.2009.04.001",
            "firstpage": "318",
            "issn": "19313128",
            "lastpage": "328",
            "pmid": "19380111",
            "pub_year": 2009,
            "title": "Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell",
            "volume": "5"
        },
        "b0375": null,
        "b0380": {
            "authors": [
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Domnich"
                },
                {
                    "first": "Donatella",
                    "initial": "D.",
                    "last": "Panatto"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Klementievna Arbuzova"
                },
                {
                    "first": "Alessio",
                    "initial": "A.",
                    "last": "Signori"
                },
                {
                    "first": "Ulderico",
                    "initial": "U.",
                    "last": "Avio"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Amicizia"
                }
            ],
            "doi": "10.4161/hv.29984",
            "firstpage": "2819",
            "issn": "21645515",
            "lastpage": "2833",
            "pmid": "25483679",
            "pub_year": 2014,
            "title": "Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: Systematic review and meta-analysis",
            "volume": "10"
        },
        "b0385": {
            "authors": [
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Lobigs"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Diamond"
                }
            ],
            "doi": "10.1586/erv.11.180",
            "firstpage": "177",
            "issn": "14760584",
            "lastpage": "187",
            "pmid": "22309667",
            "pub_year": 2012,
            "title": "Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex",
            "volume": "11"
        },
        "b0390": {
            "authors": [
                {
                    "first": "Lalita",
                    "initial": "L.",
                    "last": "Priyamvada"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Hudson"
                },
                {
                    "first": "Rafi",
                    "initial": "R.",
                    "last": "Ahmed"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Wrammert"
                }
            ],
            "doi": "10.1038/emi.2017.42",
            "issn": "22221751",
            "pmid": "28487557",
            "pub_year": 2017,
            "title": "Humoral cross-reactivity between Zika and dengue viruses: Implications for protection and pathology",
            "volume": "6"
        },
        "b0395": {
            "authors": [
                {
                    "first": "Karen L.",
                    "initial": "K.L.",
                    "last": "Mansfield"
                },
                {
                    "first": "Daniel L.",
                    "initial": "D.L.",
                    "last": "Horton"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Johnson"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Alan D.T.",
                    "initial": "A.D.T.",
                    "last": "Barrett"
                },
                {
                    "first": "Derek J.",
                    "initial": "D.J.",
                    "last": "Smith"
                },
                {
                    "first": "Sareen E.",
                    "initial": "S.E.",
                    "last": "Galbraith"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Solomon"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                }
            ],
            "doi": "10.1099/vir.0.031641-0",
            "firstpage": "2821",
            "issn": "00221317",
            "lastpage": "2829",
            "pmid": "21900425",
            "pub_year": 2011,
            "title": "Flavivirus-induced antibody cross-reactivity",
            "volume": "92"
        },
        "b0400": null,
        "b0405": {
            "authors": [
                {
                    "first": "Nozyechi N.",
                    "initial": "N.N.",
                    "last": "Chidumayo"
                },
                {
                    "first": "Kentaro",
                    "initial": "K.",
                    "last": "Yoshii"
                },
                {
                    "first": "Hiroaki",
                    "initial": "H.",
                    "last": "Kariwa"
                }
            ],
            "doi": "10.1111/1348-0421.12122",
            "firstpage": "112",
            "issn": "03855600",
            "lastpage": "118",
            "pmid": "24329534",
            "pub_year": 2014,
            "title": "Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus",
            "volume": "58"
        },
        "b0410": {
            "authors": [
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Brookes"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Parsons"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Johnson"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "McElhinney"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.03.037",
            "firstpage": "4101",
            "issn": "0264410X",
            "lastpage": "4109",
            "pmid": "15964478",
            "pub_year": 2005,
            "title": "Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses",
            "volume": "23"
        },
        "b0415": {
            "authors": [
                {
                    "first": "Claudius",
                    "initial": "C.",
                    "last": "Malerczyk"
                },
                {
                    "first": "Conrad",
                    "initial": "C.",
                    "last": "Freuling"
                },
                {
                    "first": "Dieter",
                    "initial": "D.",
                    "last": "Gniel"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Giesen"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Selhorst"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "M\u00fcller"
                }
            ],
            "doi": "10.4161/21645515.2014.972741",
            "firstpage": "2799",
            "issn": "21645515",
            "lastpage": "2804",
            "pmid": "25483634",
            "pub_year": 2014,
            "title": "Cross-neutralization of antibodies induced by vaccination with Puri fied Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species",
            "volume": "10"
        },
        "b0420": {
            "authors": [
                {
                    "first": "Claudius",
                    "initial": "C.",
                    "last": "Malerczyk"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Selhorst"
                },
                {
                    "first": "No\u00ebl",
                    "initial": "N.",
                    "last": "Tordo"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Moore"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "M\u00fcller"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.06.095",
            "firstpage": "5320",
            "issn": "0264410X",
            "lastpage": "5325",
            "pmid": "19615958",
            "pub_year": 2009,
            "title": "Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains",
            "volume": "27"
        },
        "b0425": {
            "authors": [
                {
                    "first": "Sook San",
                    "initial": "S.S.",
                    "last": "Wong"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Webby"
                }
            ],
            "doi": "10.1128/CMR.00097-12",
            "firstpage": "476",
            "issn": "08938512",
            "lastpage": "492",
            "pmid": "23824369",
            "pub_year": 2013,
            "title": "Traditional and new influenza vaccines",
            "volume": "26"
        },
        "b0430": null,
        "b0435": null,
        "b0440": {
            "authors": [
                {
                    "first": "Oberdan",
                    "initial": "O.",
                    "last": "Leo"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Cunningham"
                },
                {
                    "first": "Peter L.",
                    "initial": "P.L.",
                    "last": "Stern"
                }
            ],
            "doi": "10.1016/j.pervac.2011.05.002",
            "firstpage": "25",
            "issn": "22107622",
            "lastpage": "59",
            "pub_year": 2011,
            "title": "Vaccine immunology",
            "volume": "1"
        },
        "b0445": {
            "authors": [
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Mason"
                }
            ],
            "doi": "10.1016/S0167-5699(98)01299-7",
            "firstpage": "395",
            "issn": "01675699",
            "lastpage": "404",
            "pmid": "9745202",
            "pub_year": 1998,
            "title": "A very high level of crossreactivity is an essential feature of the T- cell receptor",
            "volume": "19"
        },
        "b0450": {
            "authors": [
                {
                    "first": "Andrew K.",
                    "initial": "A.K.",
                    "last": "Sewell"
                }
            ],
            "doi": "10.1038/nri3279",
            "firstpage": "669",
            "issn": "14741733",
            "lastpage": "677",
            "pmid": "22918468",
            "pub_year": 2012,
            "title": "Why must T cells be cross-reactive?",
            "volume": "12"
        },
        "b0455": {
            "authors": [
                {
                    "first": "T. Petteri",
                    "initial": "T.P.",
                    "last": "Arstila"
                },
                {
                    "first": "Armanda",
                    "initial": "A.",
                    "last": "Casrouge"
                },
                {
                    "first": "V\u00e9ronique",
                    "initial": "V.",
                    "last": "Baron"
                },
                {
                    "first": "Jos",
                    "initial": "J.",
                    "last": "Even"
                },
                {
                    "first": "Jean",
                    "initial": "J.",
                    "last": "Kanellopoulos"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Kourilsky"
                }
            ],
            "doi": "10.1126/science.286.5441.958",
            "firstpage": "958",
            "issn": "00368075",
            "lastpage": "961",
            "pmid": "10542151",
            "pub_year": 1999,
            "title": "A direct estimate of the human \u03b1\u03b2 T cell receptor diversity",
            "volume": "286"
        },
        "b0460": {
            "authors": [
                {
                    "first": "Yiyuan",
                    "initial": "Y.",
                    "last": "Yin"
                },
                {
                    "first": "Roy A.",
                    "initial": "R.A.",
                    "last": "Mariuzza"
                }
            ],
            "doi": "10.1016/j.immuni.2009.12.002",
            "firstpage": "849",
            "issn": "10747613",
            "lastpage": "851",
            "pmid": "20064442",
            "pub_year": 2009,
            "title": "The Multiple Mechanisms of T Cell Receptor Cross-reactivity",
            "volume": "31"
        },
        "b0465": {
            "authors": [
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Kim"
                },
                {
                    "first": "Erin R.",
                    "initial": "E.R.",
                    "last": "Laskowich"
                },
                {
                    "first": "Rasappa G.",
                    "initial": "R.G.",
                    "last": "Arumugham"
                },
                {
                    "first": "Raymond E.",
                    "initial": "R.E.",
                    "last": "Kaiser"
                },
                {
                    "first": "Gregory J.",
                    "initial": "G.J.",
                    "last": "MacMichael"
                }
            ],
            "doi": "10.1016/j.ab.2005.09.022",
            "firstpage": "262",
            "issn": "00032697",
            "lastpage": "274",
            "pmid": "16266683",
            "pub_year": 2005,
            "title": "Determination of saccharide content in pneumococcal polysaccharides and conjugate vaccines by GC-MSD",
            "volume": "347"
        },
        "b0470": {
            "authors": [
                {
                    "first": "Giuseppe A.",
                    "initial": "G.A.",
                    "last": "Sautto"
                },
                {
                    "first": "Greg A.",
                    "initial": "G.A.",
                    "last": "Kirchenbaum"
                },
                {
                    "first": "Ted M.",
                    "initial": "T.M.",
                    "last": "Ross"
                }
            ],
            "doi": "10.1186/s12985-017-0918-y",
            "issn": "1743422X",
            "pmid": "29370862",
            "pub_year": 2018,
            "title": "Towards a universal influenza vaccine: Different approaches for one goal",
            "volume": "15"
        },
        "b0475": {
            "authors": [
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                }
            ],
            "doi": "10.1016/B978-1-4557-0090-5.00004-5",
            "firstpage": "14",
            "lastpage": "32",
            "pub_year": 2012,
            "title": "Vaccine immunology"
        },
        "b0480": {
            "authors": [
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                },
                {
                    "first": "Alberta",
                    "initial": "A.",
                    "last": "Di Pasquale"
                }
            ],
            "doi": "10.1080/21645515.2016.1225635",
            "firstpage": "19",
            "issn": "21645515",
            "lastpage": "33",
            "pmid": "27636098",
            "pub_year": 2017,
            "title": "From discovery to licensure, the Adjuvant System story",
            "volume": "13"
        },
        "b0485": null,
        "b0490": {
            "authors": [
                {
                    "first": "Alberta",
                    "initial": "A.",
                    "last": "Di Pasquale"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Preiss"
                },
                {
                    "first": "Fernanda Tavares",
                    "initial": "F.T.",
                    "last": "Da Silva"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                }
            ],
            "firstpage": "320",
            "issn": "2076393X",
            "lastpage": "343",
            "pub_year": 2015,
            "title": "Vaccine adjuvants: From 1920 to 2015 and beyond",
            "volume": "3"
        },
        "b0495": null,
        "b0500": {
            "authors": [
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Webby"
                },
                {
                    "first": "Eric A.",
                    "initial": "E.A.",
                    "last": "Weaver"
                }
            ],
            "doi": "10.1371/journal.pone.0140702",
            "issn": "19326203",
            "pmid": "26469190",
            "pub_year": 2015,
            "title": "Centralized consensus hemagglutinin genes induce protective immunity against H1, H3 and H5 influenza viruses",
            "volume": "10"
        }
    },
    "body_text": [
        {
            "endOffset": 20966,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 20965,
                    "startOffset": 20958
                },
                "b0055": {
                    "endOffset": 20965,
                    "startOffset": 20958
                },
                "b0060": {
                    "endOffset": 20965,
                    "startOffset": 20958
                },
                "b0065": {
                    "endOffset": 20965,
                    "startOffset": 20958
                }
            },
            "secId": "s0020",
            "sentence": "A decline in the incidence of IPD due to 6A has also been observed in subsequent surveillance studies in various countries following PCV-7 introduction [10\u201313].",
            "startOffset": 20806,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 37725,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0350": {
                    "endOffset": 37714,
                    "startOffset": 37707
                },
                "b0355": {
                    "endOffset": 37714,
                    "startOffset": 37707
                }
            },
            "secId": "s0040",
            "sentence": "For example, vaccination with an AS03-adjuvanted A/H5N1/Vietnam/1194/2004 (clade 1) vaccine resulted in cross-clade immunity against A/H5N1/Indonesia/5/2005 (clade 2.1), A/H5N1/turkey/Turkey/1/2005 (clade 2.2), and A/H5N1/Anhui/1/2005 (clade 2.3) (seroconversion rates 75\u201385%) despite significant antigenic variability between these clades [70,71] (Table 1).",
            "startOffset": 37367,
            "title": "Influenza"
        },
        {
            "endOffset": 28937,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 28936,
                    "startOffset": 28932
                }
            },
            "secId": "s0030",
            "sentence": "In a pooled analysis, the monovalent vaccine was found to have, in high\u2013middle income countries, a 77% (95% CI 58\u201386%) effectiveness against the G1P[8] vaccine strain, 72% (95% CI 49\u201384%) against partially heterotypic strains (G3P[8], G4P[8], G9P[8]), and 67% (95% CI 52\u201377%) against a fully heterotypic strain (G2P[4]) [37].",
            "startOffset": 28612,
            "title": "Rotavirus"
        },
        {
            "endOffset": 18366,
            "parents": [],
            "secId": "s0005",
            "sentence": "Representative data (Table 1) \u2013 showing the additional protection provided by vaccines across a range of vaccine-preventable diseases \u2013 will be discussed in this expert review article, along with possible modes of action to complete the understanding of cross-reactivity as an inherent property of the human immune system.",
            "startOffset": 18044,
            "title": "Introduction"
        },
        {
            "endOffset": 46100,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0460": {
                    "endOffset": 46099,
                    "startOffset": 46095
                }
            },
            "secId": "s0060",
            "sentence": "Various mechanisms have been suggested to explain how T-cell receptor cross-reactivity may allow the limited T-cell pool to recognize a myriad of potential antigens: (1) induced fit; (2) differential T-cell receptor docking; (3) structural degeneracy; (4) molecular mimicry; and (5) antigen-dependent tuning of peptide-major histocompatibility complex flexibility [92].",
            "startOffset": 45731,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 24834,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0005": {
                    "endOffset": 24833,
                    "startOffset": 24830
                }
            },
            "secId": "s0025",
            "sentence": "Further examination of the data from this study showed that the AS04-HPV-16/18 vaccine provided significant cross-protection against 6-month persistent infection and CIN2+ (with or without HPV-16/18 infection) associated with five non-vaccine types for the HPV-na\u00efve cohort; and with four non-vaccine types for the total vaccinated cohort (Table 3) [1].",
            "startOffset": 24481,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 25928,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0025",
            "sentence": "Studies of the HPV-6/11/16/18 vaccine have also demonstrated reductions in HPV infection due to non-vaccine types.",
            "startOffset": 25814,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 17696,
            "parents": [],
            "secId": "s0005",
            "sentence": "The extent of cross-protection is sometimes assessed during vaccine trials.",
            "startOffset": 17621,
            "title": "Introduction"
        },
        {
            "endOffset": 31879,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0265": {
                    "endOffset": 31878,
                    "startOffset": 31874
                }
            },
            "secId": "s0035",
            "sentence": "However, it is likely that MATS underestimates MenB strain coverage because it does not include the potential for cross-protection [53].",
            "startOffset": 31743,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 51189,
            "parents": [],
            "secId": "s0075",
            "sentence": "Of course, in addition to providing protection against infection/disease, cross-protection is also likely to have beneficial impacts on carriage and circulation, thereby providing some indirect (herd) protection.",
            "startOffset": 50977,
            "title": "Conclusions"
        },
        {
            "endOffset": 51446,
            "parents": [],
            "secId": "s0075",
            "sentence": "The observed effect of cross-reactivity is based on the intrinsic properties of the human adaptive immune system, namely the polyclonal nature of the humoral response and the capability of T- and B-cell receptors to recognize a variety of similar antigens.",
            "startOffset": 51190,
            "title": "Conclusions"
        },
        {
            "endOffset": 38901,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0045",
            "sentence": "Available vaccines are based on inactivated whole TBEV.",
            "startOffset": 38846,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 43036,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "This triggers a selective process, resulting in selection and proliferation of B cells capable of producing antibodies that bind to this epitope in a process called affinity maturation.",
            "startOffset": 42851,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 25814,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 25813,
                    "startOffset": 25809
                }
            },
            "secId": "s0025",
            "sentence": "Furthermore, ecological data from England suggest that vaccination with the AS04-HPV-16/18 vaccine has resulted in up to a 50% reduction in the incidence of genital warts [25].",
            "startOffset": 25638,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 33096,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0280": {
                    "endOffset": 33095,
                    "startOffset": 33091
                }
            },
            "secId": "s0035",
            "sentence": "Another study, using hSBA assays with pooled sera from vaccinated subjects, reported that MenB-4C might provide coverage against nine MenX isolates from Africa (but not two unrelated MenX isolates from France) [56].",
            "startOffset": 32881,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 33414,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0035",
            "sentence": "These preliminary data suggest that additional protection against non-MenB serogroups may be provided by the MenB-4C vaccine.",
            "startOffset": 33289,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 47816,
            "parents": [],
            "secId": "s0065",
            "sentence": "The latter approach could result in the ultimate cross-protective influenza vaccine.",
            "startOffset": 47732,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 42850,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "In the cascade of the adaptive immune response, an epitope (also called antigenic determinant, which is the structure recognized by the immune system) is presented to na\u00efve B cells and recognized with various levels of affinity.",
            "startOffset": 42622,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 43634,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "An immune response to an antigen therefore classically raises many different antibodies to the various exposed epitopes on the antigen.",
            "startOffset": 43499,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 44647,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "Some of these have high specificity to a small number of epitopes, while others have low specificity to a wider range of epitopes.",
            "startOffset": 44517,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 30618,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0035",
            "sentence": "However, antigenic diversity and immunodominance of certain porin A antigens resulted in monovalent MenB vaccines with limited cross-reactivity.",
            "startOffset": 30474,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 39721,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0390": {
                    "endOffset": 39627,
                    "startOffset": 39623
                }
            },
            "secId": "s0045",
            "sentence": "As recently reviewed by Priyamvada et al. [78], there is also evidence of interspecies cross-reactivity between dengue virus and Zika virus.",
            "startOffset": 39581,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 27577,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 27576,
                    "startOffset": 27572
                }
            },
            "secId": "s0030",
            "sentence": "Although the role of these proteins in cross-reactivity has not been fully elucidated, the best evidence of heterologous protection arises from empirical observations of natural rotavirus infections [35].",
            "startOffset": 27373,
            "title": "Rotavirus"
        },
        {
            "endOffset": 23116,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22906,
                    "startOffset": 22902
                },
                "b0095": {
                    "endOffset": 23115,
                    "startOffset": 23111
                }
            },
            "secId": "s0025",
            "sentence": "Over 150 HPV types have been identified [18], but two (HPV-16 and HPV-18, both \u201chigh-risk\u201d oncogenic types) account for approximately 70% of cervical cancer cases (in terms of oncogenesis), with HPV-31/33/35/45/52/58 accounting for most other cases [19].",
            "startOffset": 22862,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 44791,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "There is also a level of cross-reactivity in the T cells.",
            "startOffset": 44734,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 27189,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 27188,
                    "startOffset": 27184
                }
            },
            "secId": "s0030",
            "sentence": "A range of genotypes may be characterized on the basis of G-P combinations, with G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8] being the most common in the pre-rotavirus vaccine era [34].",
            "startOffset": 27005,
            "title": "Rotavirus"
        },
        {
            "endOffset": 39902,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0395": {
                    "endOffset": 39901,
                    "startOffset": 39894
                },
                "b0400": {
                    "endOffset": 39901,
                    "startOffset": 39894
                },
                "b0405": {
                    "endOffset": 39901,
                    "startOffset": 39894
                }
            },
            "secId": "s0045",
            "sentence": "Immunization with a vaccine against a specific flavivirus has also been found to be accompanied by some degree of immunological cross-reactivity against other flaviviridae [79\u201381].",
            "startOffset": 39722,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 20553,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0035": {
                    "endOffset": 20552,
                    "startOffset": 20547
                },
                "b0040": {
                    "endOffset": 20552,
                    "startOffset": 20547
                },
                "b0045": {
                    "endOffset": 20552,
                    "startOffset": 20547
                }
            },
            "secId": "s0020",
            "sentence": "Case-control studies have reported vaccine effectiveness >75% for PCV-7, PHiD-CV, and PCV-13 against vaccine-serotype IPD [7\u20139].",
            "startOffset": 20425,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 26638,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 26548,
                    "startOffset": 26544
                }
            },
            "secId": "s0025",
            "sentence": "The AS04-HPV-16/18 vaccine contains AS04, which enhances the immune response by triggering a local cytokine response [31], while the HPV-6/11/16/18 vaccine contains amorphous aluminium hydroxyphosphate sulphate.",
            "startOffset": 26427,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 22579,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22578,
                    "startOffset": 22574
                }
            },
            "secId": "s0020",
            "sentence": "The cross-reactive antibodies to 19A induced with PCV-7 have lower opsonophagocytic activity and lower titres than the cross-reactive antibodies to 19A induced with PHiD-CV [16].",
            "startOffset": 22401,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 30033,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0240": {
                    "endOffset": 30032,
                    "startOffset": 30028
                }
            },
            "secId": "s0035",
            "sentence": "A number of monovalent and polyvalent vaccines directed against the capsular polysaccharides (CPS) of meningococcal groups A, C, W-135, and Y have been licensed and are widely used [48].",
            "startOffset": 29847,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 38568,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0370": {
                    "endOffset": 38567,
                    "startOffset": 38563
                }
            },
            "secId": "s0045",
            "sentence": "While these viruses differ in their natural history and pathogenicity profiles, they have the envelope glycoprotein \u2013 which governs membrane fusion \u2013 as a common structure [74].",
            "startOffset": 38391,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 43266,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0430": {
                    "endOffset": 43265,
                    "startOffset": 43258
                },
                "b0435": {
                    "endOffset": 43265,
                    "startOffset": 43258
                }
            },
            "secId": "s0060",
            "sentence": "Another is the presence of T-helper cells, which are essential for the development of a strong and lasting immune response [86,87].",
            "startOffset": 43135,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 42121,
            "parents": [],
            "secId": "s0055",
            "sentence": "Consequently, vaccination using specific antigen targets can induce immune responses towards additional pathogen strains (and sometimes even different species).",
            "startOffset": 41961,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 46836,
            "parents": [],
            "refoffsets": {
                "b0465": {
                    "endOffset": 46835,
                    "startOffset": 46831
                }
            },
            "secId": "s0065",
            "sentence": "As one example, the 19F antigen that is included in PHiD-CV was subsequently found to provide protection against 19A IPD, presumably due to the very similar structures of these two serotypes [93].",
            "startOffset": 46640,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 37933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0360": {
                    "endOffset": 37932,
                    "startOffset": 37925
                },
                "b0365": {
                    "endOffset": 37932,
                    "startOffset": 37925
                }
            },
            "secId": "s0040",
            "sentence": "Cross-reactivity has also been reported following immunization with adjuvanted pandemic H1N1 vaccines [72,73].",
            "startOffset": 37823,
            "title": "Influenza"
        },
        {
            "endOffset": 39424,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0380": {
                    "endOffset": 39423,
                    "startOffset": 39419
                }
            },
            "secId": "s0045",
            "sentence": "As shown in a recent review of 14 serological studies, both European vaccines induce strong, persistent antibody responses to a wide variety of TBEV types, with very high seroconversion/seropositivity rates (Table 4) [76].",
            "startOffset": 39202,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 43498,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0430": {
                    "endOffset": 43497,
                    "startOffset": 43490
                },
                "b0440": {
                    "endOffset": 43497,
                    "startOffset": 43490
                }
            },
            "secId": "s0060",
            "sentence": "This leads to proliferation of all the different clones and is known as a polyclonal response [86,88].",
            "startOffset": 43396,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 19914,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 19742,
                    "startOffset": 19739
                },
                "b0030": {
                    "endOffset": 19913,
                    "startOffset": 19910
                }
            },
            "secId": "s0020",
            "sentence": "Although around 90 different Streptococcus pneumoniae serotypes have been identified [5], seven (4, 6B, 9V, 14, 18C, 19F, and 23F) caused the majority of invasive pneumococcal disease (IPD) in North America before the introduction of pneumococcal vaccines [6].",
            "startOffset": 19654,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 17620,
            "parents": [],
            "secId": "s0005",
            "sentence": "\u201cCross-protection\u201d implies clinically significant protection against infection/disease due to an immune response elicited against a related organism, i.e. when \u201ccross-reactivity\u201d results in a measurable clinical impact.",
            "startOffset": 17401,
            "title": "Introduction"
        },
        {
            "endOffset": 29846,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 29845,
                    "startOffset": 29841
                }
            },
            "secId": "s0035",
            "sentence": "There are 13 serogroups of Neisseria meningitidis, but most invasive human disease is due to serogroups A, B, C, W-135, X and Y [47].",
            "startOffset": 29713,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 35789,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0320": {
                    "endOffset": 35467,
                    "startOffset": 35460
                },
                "b0325": {
                    "endOffset": 35467,
                    "startOffset": 35460
                },
                "b0330": {
                    "endOffset": 35467,
                    "startOffset": 35460
                },
                "b0335": {
                    "endOffset": 35777,
                    "startOffset": 35773
                }
            },
            "secId": "s0040",
            "sentence": "As reviewed by various authors [64\u201366], immunogenicity studies have shown that influenza vaccines against H1N1, H3N2, and B influenza viruses can induce seroprotection against related strains (e.g. a vaccine containing the seasonal A/H1N1/Beijing/262/95 virus can induce seroprotection against the new pandemic A/H1N1/New Caledonia/20/99 virus [67]) (Table 1).",
            "startOffset": 35429,
            "title": "Influenza"
        },
        {
            "endOffset": 18043,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, confirmatory evidence normally comes from post-licensure studies following the implementation of immunization programmes.",
            "startOffset": 17911,
            "title": "Introduction"
        },
        {
            "endOffset": 25637,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 25636,
                    "startOffset": 25632
                }
            },
            "secId": "s0025",
            "sentence": "The AS04-HPV-16/18 vaccine has also been found to provide moderate cross-protection against persistent infection with low-risk non-vaccine genotypes associated with genital warts, with vaccine efficacies against 6-month persistent infection against HPV-6/11 of 34.5% (95% CI 11.3\u201351.8%) and against HPV-74 of 49.5% (95% CI 21.0\u201368.3%) [24].",
            "startOffset": 25297,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 34759,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0310": {
                    "endOffset": 34758,
                    "startOffset": 34754
                }
            },
            "secId": "s0035",
            "sentence": "Subjects who received a complete MeNZB vaccination schedule were found to be significantly less likely to have gonorrhoea than those who did not (p < 0.0001), with an estimated vaccine effectiveness of 31% (95% CI 21\u201339%) [62].",
            "startOffset": 34532,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 39036,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0375": {
                    "endOffset": 39035,
                    "startOffset": 39031
                }
            },
            "secId": "s0045",
            "sentence": "In Europe, two licensed vaccines directed against TBEV-Eu are available: Encepur (GSK, Belgium) and FSME-Immun (Baxter, Austria) [75].",
            "startOffset": 38902,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 46640,
            "parents": [],
            "secId": "s0065",
            "sentence": "Antigens that result in the generation of antibodies against a wide variety of naturally occurring antigens can then be used preferentially.",
            "startOffset": 46500,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 48030,
            "parents": [],
            "secId": "s0070",
            "sentence": "As the adaptive immune system recognizes a pathogen by its antigens, the quality and quantity of the adaptive immune response are determined by the way these antigens are presented.",
            "startOffset": 47849,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 48745,
            "parents": [],
            "secId": "s0070",
            "sentence": "Adjuvants provide an early stimulus in clonal expansion, by activating antigen-presenting cells, which can further contribute to a broader polyclonal response.",
            "startOffset": 48586,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 40475,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0410": {
                    "endOffset": 40474,
                    "startOffset": 40470
                }
            },
            "secId": "s0050",
            "sentence": "Rabies is caused by the rabies virus and other phylogenetically related viruses, all from the genus Lyssavirus [82].",
            "startOffset": 40359,
            "title": "Rabies"
        },
        {
            "endOffset": 51661,
            "parents": [],
            "secId": "s0075",
            "sentence": "The evidence of vaccine effectiveness beyond that predicted solely by their antigen content has changed our understanding of the full impact \u2013 and cost-effectiveness \u2013 of immunization programmes with some vaccines.",
            "startOffset": 51447,
            "title": "Conclusions"
        },
        {
            "endOffset": 34846,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0315": {
                    "endOffset": 34845,
                    "startOffset": 34841
                }
            },
            "secId": "s0040",
            "sentence": "Human influenza viruses are classified into three types (A, B, and C) [63].",
            "startOffset": 34771,
            "title": "Influenza"
        },
        {
            "endOffset": 45343,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0445": {
                    "endOffset": 45342,
                    "startOffset": 45335
                },
                "b0450": {
                    "endOffset": 45342,
                    "startOffset": 45335
                }
            },
            "secId": "s0060",
            "sentence": "Following the one-pathogen-one-clonotype concept, recognition of >1015 potential foreign peptides, which is necessary for effective immunity, would require 1015 T cells, which would weigh >500 kg [89,90].",
            "startOffset": 45139,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 45571,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0450": {
                    "endOffset": 45570,
                    "startOffset": 45563
                },
                "b0455": {
                    "endOffset": 45570,
                    "startOffset": 45563
                }
            },
            "secId": "s0060",
            "sentence": "There are about 1012 T cells in a human and <108 distinct T-cell receptors in the human na\u00efve T-cell pool [90,91].",
            "startOffset": 45457,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 52232,
            "parents": [],
            "secId": "s0075",
            "sentence": "For vaccines against pathogens with important antigenic variability (e.g. pandemic influenza), cross-reactivity is actually an essential part of the vaccine design strategy to ensure optimal effectiveness.",
            "startOffset": 52027,
            "title": "Conclusions"
        },
        {
            "endOffset": 20805,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0035": {
                    "endOffset": 20794,
                    "startOffset": 20791
                }
            },
            "secId": "s0020",
            "sentence": "For example, a US case\u2013control study reported that PCV-7 was effective against IPD caused by serotype 6A [7] (Table 2).",
            "startOffset": 20686,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 20364,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "These include a 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, Synflorix, GSK, Belgium) and a 13-valent pneumococcal-diphtheria cross-reacting material 197 protein conjugate vaccine (PCV-13, Prevenar 13, Pfizer, USA).",
            "startOffset": 20097,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 31093,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 31092,
                    "startOffset": 31088
                }
            },
            "secId": "s0035",
            "sentence": "To find alternative antigenic targets, MenB surface antigens with high immunogenicity, including the factor H binding protein (fHbp), neisseria adhesin A (NadA), and neisseria heparin binding antigen (NHBA) were identified by reverse vaccinology [47].",
            "startOffset": 30842,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 41960,
            "parents": [],
            "secId": "s0055",
            "sentence": "Conservation is also seen across more phylogenetically distant variants of the same species and even between species, as illustrated with the examples of smallpox and BCG vaccine previously mentioned.",
            "startOffset": 41760,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 18961,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0015": {
                    "endOffset": 18950,
                    "startOffset": 18947
                }
            },
            "secId": "s0015",
            "sentence": "The observation that natural infection with cowpox provided protection against smallpox ultimately led to the development of vaccination against smallpox [3] (Table 1).",
            "startOffset": 18793,
            "title": "Vaccinia and mycobacteria"
        },
        {
            "endOffset": 32650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0270": {
                    "endOffset": 32649,
                    "startOffset": 32645
                }
            },
            "secId": "s0035",
            "sentence": "Of these, 56% exceeded immune correlates of protection thresholds for at least one of the antigens included in MenB-4C: MenC (64%); MenW-135 (63%); and MenY (37%) [54].",
            "startOffset": 32482,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 44734,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "This polyclonal response is one of the main underlying principles of cross-reactivity.",
            "startOffset": 44648,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 38698,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0045",
            "sentence": "Intra-species cross-reactivity between distinct subtypes is well illustrated in the experience seen with immunization against TBE.",
            "startOffset": 38568,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 34233,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0300": {
                    "endOffset": 34232,
                    "startOffset": 34228
                }
            },
            "secId": "s0035",
            "sentence": "Meningitis vaccines may therefore provide some clinical protection against gonorrhoea, for which there is currently no specific effective vaccine [60].",
            "startOffset": 34082,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 40898,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0415": {
                    "endOffset": 40897,
                    "startOffset": 40893
                }
            },
            "secId": "s0050",
            "sentence": "The purified chick embryo cell vaccine has additionally shown cross-reactivity against Duvenhage virus and Bokeloh bat lyssavirus [83].",
            "startOffset": 40763,
            "title": "Rabies"
        },
        {
            "endOffset": 49275,
            "parents": [],
            "refoffsets": {
                "b0350": {
                    "endOffset": 49274,
                    "startOffset": 49267
                },
                "b0355": {
                    "endOffset": 49274,
                    "startOffset": 49267
                }
            },
            "secId": "s0070",
            "sentence": "Similarly, as mentioned previously, an AS03-adjuvanted recombinant clade 1 H5N1 pre-pandemic vaccine has been shown to elicit a broad clade 2 cross-reactive immunity, while the antigen alone did not induce cross-reactive antibodies [70,71].",
            "startOffset": 49035,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 51858,
            "parents": [],
            "secId": "s0075",
            "sentence": "In several instances, the impact of immunization as we know it would not be the same without cross-reactivity, and this should therefore be taken into consideration when implementing new regimens.",
            "startOffset": 51662,
            "title": "Conclusions"
        },
        {
            "endOffset": 24480,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 24479,
                    "startOffset": 24475
                }
            },
            "secId": "s0025",
            "sentence": "These increases in observed vaccine efficacy appear to be due to cross-protection [22].",
            "startOffset": 24393,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 36252,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0340": {
                    "endOffset": 36241,
                    "startOffset": 36237
                }
            },
            "secId": "s0040",
            "sentence": "A placebo-controlled study has reported potential cross-protection of a non-adjuvanted intramuscularly administered seasonal influenza vaccine (containing A/Brisbane/59/2007(H1N1)-like) against pandemic H1N1 influenza [68] (Table 1).",
            "startOffset": 36019,
            "title": "Influenza"
        },
        {
            "endOffset": 28289,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0030",
            "sentence": "This implies broad immunological cross-reactivity and clinical protection against disease induced by non-vaccine serotypes.",
            "startOffset": 28166,
            "title": "Rotavirus"
        },
        {
            "endOffset": 24392,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 24391,
                    "startOffset": 24387
                }
            },
            "secId": "s0025",
            "sentence": "In a large clinical trial, overall efficacy of AS04-adjuvanted HPV-16/18 vaccine against various cervical intraepithelial neoplasia (CIN) endpoints (due to any HPV type) in initially HPV-na\u00efve women after 4 years were greater than the expected efficacy based on the proportions of HPV-16/18-associated cases in the control arm and that predicted from vaccine efficacy against HPV-16/18 alone (Fig. 1B) [22].",
            "startOffset": 23985,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 34081,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0295": {
                    "endOffset": 34080,
                    "startOffset": 34076
                }
            },
            "secId": "s0035",
            "sentence": "Lastly, there is substantial (80\u201390%) genetic homology between Neisseria species, including N. meningitidis and N. gonorrhoeae [59].",
            "startOffset": 33949,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 47011,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 47010,
                    "startOffset": 47006
                }
            },
            "secId": "s0065",
            "sentence": "Although this cross-protection developed by chance rather than by design, this knowledge has led to the search for conserved antigens, e.g. when designing MenB vaccines [47].",
            "startOffset": 46837,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 36775,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0320": {
                    "endOffset": 36774,
                    "startOffset": 36770
                }
            },
            "secId": "s0040",
            "sentence": "In addition, some studies showed an enhanced cross-protection with intradermally administered vaccines and intramuscularly administered microfluidized emulsion (MF59)-adjuvanted vaccines compared to conventional intramuscular administration of unadjuvanted vaccines [64].",
            "startOffset": 36504,
            "title": "Influenza"
        },
        {
            "endOffset": 34999,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "Influenza A viruses are divided into multiple subtypes based on surface haemagglutinin (H) and neuraminidase (N) proteins (e.g. H1N1, H3N2, H5N1, H7N9).",
            "startOffset": 34847,
            "title": "Influenza"
        },
        {
            "endOffset": 25006,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25005,
                    "startOffset": 25001
                }
            },
            "secId": "s0025",
            "sentence": "These observations were recently confirmed in a cross-sectional study conducted in Scotland 7 years after the introduction of an AS04-HPV-16/18 vaccination programme [23].",
            "startOffset": 24835,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 38845,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0375": {
                    "endOffset": 38844,
                    "startOffset": 38840
                }
            },
            "secId": "s0045",
            "sentence": "TBEVs are subdivided into three main types: TBEV-Eu (a European subtype); TBEV-Fe (a Far-Eastern subtype); and TBEV-Sib (a Siberian subtype) [75].",
            "startOffset": 38699,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 43395,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "A single antigen typically contains various different epitopes, which can be recognized by multiple different clones of B cells.",
            "startOffset": 43267,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 45138,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "It has been proposed that the ability of a T-cell receptor to recognize more antigens is an evolutionary necessity.",
            "startOffset": 45023,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 30473,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0035",
            "sentence": "Initially, vaccines against MenB outer membrane vesicles (OMVs) were developed, selecting the MenB porin A as the vaccine antigen.",
            "startOffset": 30343,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 47417,
            "parents": [],
            "refoffsets": {
                "b0320": {
                    "endOffset": 47293,
                    "startOffset": 47286
                },
                "b0325": {
                    "endOffset": 47293,
                    "startOffset": 47286
                },
                "b0330": {
                    "endOffset": 47293,
                    "startOffset": 47286
                }
            },
            "secId": "s0065",
            "sentence": "However, despite some cross-reactivity (especially with adjuvanted vaccines) [64\u201366], seasonal influenza vaccines offer only low levels of protection against seasonal influenza, or against pandemic influenza.",
            "startOffset": 47209,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 39581,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0385": {
                    "endOffset": 39580,
                    "startOffset": 39576
                }
            },
            "secId": "s0045",
            "sentence": "Another review has discussed evidence suggesting cross-protective capabilities of vaccines against different Japanese encephalitis serocomplex viruses [77].",
            "startOffset": 39425,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 34531,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0310": {
                    "endOffset": 34530,
                    "startOffset": 34526
                }
            },
            "secId": "s0035",
            "sentence": "A recent retrospective case\u2013control study in New Zealand has specifically evaluated the effect of a specific MenB OMV vaccine (MeNZB) on gonorrhoea [62].",
            "startOffset": 34378,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 33949,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 33880,
                    "startOffset": 33873
                },
                "b0175": {
                    "endOffset": 33880,
                    "startOffset": 33873
                }
            },
            "secId": "s0035",
            "sentence": "MenB-FHbp has also been predicted to elicit responses to diverse MenB strains [32,35], although there is, as yet, limited clinical data with this vaccine.",
            "startOffset": 33795,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 40762,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0415": {
                    "endOffset": 40751,
                    "startOffset": 40744
                },
                "b0420": {
                    "endOffset": 40751,
                    "startOffset": 40744
                }
            },
            "secId": "s0050",
            "sentence": "Human diploid cell and purified chick embryo cell rabies vaccines in particular, have been shown to elicit cross-reactive neutralizing antibodies against Australian bat lyssavirus and European bat lyssavirus [83,84] (Table 1).",
            "startOffset": 40536,
            "title": "Rabies"
        },
        {
            "endOffset": 23197,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0025",
            "sentence": "Of the low-risk types, HPV-6/11 are most commonly associated with genital warts.",
            "startOffset": 23117,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 26767,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 26766,
                    "startOffset": 26762
                }
            },
            "secId": "s0030",
            "sentence": "Based on VP6 genetic variability and serological reactivity, rotaviruses are classified into eight groups (A\u2013H) [32].",
            "startOffset": 26650,
            "title": "Rotavirus"
        },
        {
            "endOffset": 50248,
            "parents": [],
            "secId": "s0070",
            "sentence": "Antigen-delivery platforms may also enhance the immune response \u2013 by delivering the vaccine antigens to the right compartments for optimal expression and processing \u2013 and hence potentially enhance polyclonal responses and broaden the range of protective immunity.",
            "startOffset": 49985,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 28165,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 28164,
                    "startOffset": 28157
                },
                "b0190": {
                    "endOffset": 28164,
                    "startOffset": 28157
                }
            },
            "secId": "s0030",
            "sentence": "Despite clear differences in vaccine valency, data suggest that both vaccines have similar effectiveness against rotavirus gastroenteritis (RVGE) [37,38].",
            "startOffset": 28011,
            "title": "Rotavirus"
        },
        {
            "endOffset": 36018,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0320": {
                    "endOffset": 36017,
                    "startOffset": 36010
                },
                "b0325": {
                    "endOffset": 36017,
                    "startOffset": 36010
                }
            },
            "secId": "s0040",
            "sentence": "It is known that this is linked to how much the vaccine strains \u201cmatch\u201d the features of the circulating strains each season [64,65].",
            "startOffset": 35886,
            "title": "Influenza"
        },
        {
            "endOffset": 37822,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0350": {
                    "endOffset": 37821,
                    "startOffset": 37814
                },
                "b0355": {
                    "endOffset": 37821,
                    "startOffset": 37814
                }
            },
            "secId": "s0040",
            "sentence": "Interestingly, a non-adjuvanted version of this vaccine did not elicit cross-reactivity [70,71].",
            "startOffset": 37726,
            "title": "Influenza"
        },
        {
            "endOffset": 21817,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "The differences between the observed clinical impacts of PCV-7 and PHiD-CV on 19A IPD illustrate the importance of vaccine design on the protective immune response to closely related antigens.",
            "startOffset": 21625,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 44199,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "Such antigen\u2013antibody interactions are mediated by their respective binding site (i.e. epitope\u2013paratope) interactions, which range in respect to their strength, or affinity.",
            "startOffset": 44026,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 28611,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0195": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0200": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0205": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0210": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0215": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0220": {
                    "endOffset": 28460,
                    "startOffset": 28453
                },
                "b0225": {
                    "endOffset": 28610,
                    "startOffset": 28603
                },
                "b0230": {
                    "endOffset": 28610,
                    "startOffset": 28603
                }
            },
            "secId": "s0030",
            "sentence": "Further evidence for cross-protection with the monovalent rotavirus vaccine has been obtained from studies conducted across Latin America, Africa, Europe, and Asia [39\u201344], which showed substantial efficacy against RVGE due to the vaccine type (G1[P8]) and against disease due to a range of other strains (Fig. 2) [45,46].",
            "startOffset": 28289,
            "title": "Rotavirus"
        },
        {
            "endOffset": 21081,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0035": {
                    "endOffset": 21048,
                    "startOffset": 21042
                },
                "b0050": {
                    "endOffset": 21080,
                    "startOffset": 21073
                },
                "b0055": {
                    "endOffset": 21080,
                    "startOffset": 21073
                },
                "b0060": {
                    "endOffset": 21080,
                    "startOffset": 21073
                },
                "b0070": {
                    "endOffset": 21048,
                    "startOffset": 21042
                }
            },
            "secId": "s0020",
            "sentence": "However, PCV-7 has shown little/no efficacy against 19A in clinical trials [7,14] or surveillance studies [10\u201312].",
            "startOffset": 20967,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 37074,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "This is important as it potentially broadens the vaccine effectiveness in this disease that is caused by antigenically unstable viruses.",
            "startOffset": 36938,
            "title": "Influenza"
        },
        {
            "endOffset": 38065,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0345": {
                    "endOffset": 38064,
                    "startOffset": 38060
                }
            },
            "secId": "s0040",
            "sentence": "Overall, these findings have welcome implications regarding vaccine stockpiling when preparing for future influenza pandemics [69].",
            "startOffset": 37934,
            "title": "Influenza"
        },
        {
            "endOffset": 42250,
            "parents": [],
            "secId": "s0055",
            "sentence": "This forms the basis of cross- protection in vaccination, in which clinical protection beyond the target antigen(s) is observed.",
            "startOffset": 42122,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 33794,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0035",
            "sentence": "For the MenB-FHbp vaccine, an alternative system, the Meningococcal Antigen Surface Expression (MEASURE) assay, which quantifies the fHBP cell surface concentration, is used.",
            "startOffset": 33620,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 32317,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0035",
            "sentence": "Studies using either MATS data with predicted human serum bactericidal antibody (hSBA) responses to meningitis serogroups (C, W, and Y) or directly measuring hSBA responses using sera from subjects immunized with MenB-4C vaccine support this assumption (Table 1).",
            "startOffset": 32054,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 21982,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "While both vaccines include the 19F antigen, there appears to be a qualitative difference in their immune response in terms of protection against 19A IPD (Table 2).",
            "startOffset": 21818,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 31519,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0255": {
                    "endOffset": 31518,
                    "startOffset": 31514
                }
            },
            "secId": "s0035",
            "sentence": "Another vaccine, MenB-FHbp (Trumenba, Pfizer, USA), a bivalent vaccine containing two antigenically distinct fHbp variants is also available in the US and Europe [51].",
            "startOffset": 31352,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 39201,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0375": {
                    "endOffset": 39200,
                    "startOffset": 39196
                }
            },
            "secId": "s0045",
            "sentence": "In Russia, two vaccines against TBEV-Fe are available: TBE Moscow (Chumakov Institute of poliomyelitis and Viral encephalitides) and EnceVir (Microgen, Tomsk) [75].",
            "startOffset": 39037,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 36937,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "These studies suggest that adjuvanted seasonal influenza vaccines can provide some extra protection against related strains that are not included in the vaccine.",
            "startOffset": 36776,
            "title": "Influenza"
        },
        {
            "endOffset": 44516,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "As each paratope may interact with several different epitopes, both high- and low-affinity antibodies are produced following exposure of the immune system to an antigen.",
            "startOffset": 44347,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 35192,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "These are further subdivided into clades, which usually have different antigenic characteristics and are identified by numbers or by representative strains (e.g. A/Michigan/45/2015-like H1N1).",
            "startOffset": 35000,
            "title": "Influenza"
        },
        {
            "endOffset": 52489,
            "parents": [],
            "secId": "s0075",
            "sentence": "With the advent of the next generation of vaccine technologies (e.g. synthetic peptide antigens), cross-reactivity might become the solution to creating vaccines against highly antigenically and genetically diverse pathogens (e.g. rhinovirus or norovirus).",
            "startOffset": 52233,
            "title": "Conclusions"
        },
        {
            "endOffset": 32481,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0270": {
                    "endOffset": 32480,
                    "startOffset": 32476
                }
            },
            "secId": "s0035",
            "sentence": "In an Australian study, which used MATS data to predict MenB coverage with MenB-4C (76% predicted coverage), 108 non-MenB serogroup isolates were also tested [54].",
            "startOffset": 32318,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 43134,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "Binding of an antigen to a B cell represents one of the stimuli required for their proliferation.",
            "startOffset": 43037,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 21189,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 21188,
                    "startOffset": 21185
                }
            },
            "secId": "s0020",
            "sentence": "A Brazilian case\u2013control study has shown protection with PHiD-CV against IPD caused by 19A, but not 6A [8].",
            "startOffset": 21082,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 44346,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "This interaction is primarily a function of the level of epitope/paratope steric complementarity and ionic charge rather than amino acid sequence.",
            "startOffset": 44200,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 22838,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 22827,
                    "startOffset": 22823
                }
            },
            "secId": "s0020",
            "sentence": "Besides the above-mentioned cross-protection of serotype 6B against 6A, the 6B serotype contained in a 23-valent pneumococcal polysaccharide vaccine has been reported to induce cross-functional immune responses against serotypes 6A, 6C, and 6D [17] (Table 1).",
            "startOffset": 22579,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 41457,
            "parents": [],
            "refoffsets": {
                "b0425": {
                    "endOffset": 41456,
                    "startOffset": 41452
                }
            },
            "secId": "s0055",
            "sentence": "Virus targets often include surface glycoproteins such as haemagglutinin and neuraminidase proteins in influenza vaccines [85].",
            "startOffset": 41330,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 52026,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the cross-protective effects of each individual vaccine must be ascertained, as this can vary depending on factors such as epitope conservation and adjuvants.",
            "startOffset": 51859,
            "title": "Conclusions"
        },
        {
            "endOffset": 20096,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "Initial vaccination strategies utilized a 7-valent pneumococcal conjugate vaccine (PCV-7) targeting these seven serotypes, while newer vaccines include antigens from more serotypes.",
            "startOffset": 19915,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 21443,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "The inconsistencies in efficacy against 6A are likely due to the low numbers of 6A cases.",
            "startOffset": 21354,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 49476,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 49420,
                    "startOffset": 49408
                },
                "b0105": {
                    "endOffset": 49420,
                    "startOffset": 49408
                },
                "b0130": {
                    "endOffset": 49420,
                    "startOffset": 49408
                },
                "b0135": {
                    "endOffset": 49420,
                    "startOffset": 49408
                },
                "b0145": {
                    "endOffset": 49475,
                    "startOffset": 49468
                },
                "b0150": {
                    "endOffset": 49475,
                    "startOffset": 49468
                }
            },
            "secId": "s0070",
            "sentence": "Also as previously mentioned, the AS04-HPV-16/18 vaccine appears to offer broader and stronger cross-protection than HPV-6/11/16/18 [1,21,26,27], likely due to its specialized adjuvant system [29,30].",
            "startOffset": 49276,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 23592,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0025",
            "sentence": "Currently, three HPV vaccines are widely licensed: the AS04-HPV-16/18 vaccine, which is adjuvanted with 50 \u00b5g 3-O-desacyl-4'-monophosphoryl lipid A (MPL) adsorbed on aluminium salt (500 \u00b5g Al3+) (AS04) (Cervarix, GSK, Belgium) and HPV-6/11/16/18 and HPV-6/11/16/18/31/33/45/52/58 vaccines, both with amorphous aluminium hydroxyphosphate sulphate adjuvants (Gardasil and Gardasil 9, Merck, USA).",
            "startOffset": 23198,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 48394,
            "parents": [],
            "secId": "s0070",
            "sentence": "Although this results in improved reproducibility and safety, it can also result in responses that are not sufficient to subsequently provide protection against the actual pathogen.",
            "startOffset": 48213,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 42621,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "Besides the antigenic similarity described above, the phenomenon of cross-reactivity is also a consequence of the flexibility of interactions between T- and B-cell receptors and antigens, which rather than \u201cone-to-one\u201d resemble \u201cseveral-to-several\u201d and the resulting polyclonal adaptive response.",
            "startOffset": 42325,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 21353,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 21319,
                    "startOffset": 21315
                },
                "b0075": {
                    "endOffset": 21338,
                    "startOffset": 21334
                }
            },
            "secId": "s0020",
            "sentence": "However, subsequent cohort studies from Quebec and Finland have reported PHiD-CV vaccine effectiveness against serotypes 19A [14] or 6A and 19A [15] IPD (Table 2).",
            "startOffset": 21190,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 26151,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 26046,
                    "startOffset": 26042
                },
                "b0135": {
                    "endOffset": 26150,
                    "startOffset": 26146
                }
            },
            "secId": "s0025",
            "sentence": "As shown in Table 3, the HPV-6/11/16/18 vaccine provided cross-protection against HPV-31 in the HPV-na\u00efve cohort [26]; with additional low levels of cross-protection against HPV-58/59 in the intention-to-treat cohort [27].",
            "startOffset": 25929,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 17401,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17400,
                    "startOffset": 17397
                }
            },
            "secId": "s0005",
            "sentence": "This mechanism is also observed between serotypes/genotypes of the same pathogen species, e.g. cross-protection against human papillomavirus (HPV)-31/33/45 following administration of a vaccine containing HPV-16/18 [1].",
            "startOffset": 17182,
            "title": "Introduction"
        },
        {
            "endOffset": 29686,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0190": {
                    "endOffset": 29555,
                    "startOffset": 29551
                }
            },
            "secId": "s0030",
            "sentence": "These results were confirmed in a more recent meta-analysis where both vaccines provided good protection against RVGE, with non-significantly higher odds ratios for effectiveness for the monovalent vaccine (e.g. 2.23, 95% credible interval 0.72\u20135.20 against severe disease up to 2 years) [38], highlighting the importance of cross-protection with these two rotavirus vaccines even if they are based on different approaches.",
            "startOffset": 29263,
            "title": "Rotavirus"
        },
        {
            "endOffset": 49725,
            "parents": [],
            "secId": "s0070",
            "sentence": "How the various different adjuvants are able to activate innate cells and mechanisms, and how this translates into enhanced and modulated adaptive immune responses \u2013 particularly cross-reactivity/cross-protection \u2013 has not yet been fully elucidated.",
            "startOffset": 49476,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 32053,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 32052,
                    "startOffset": 32048
                }
            },
            "secId": "s0035",
            "sentence": "Inclusion of the sub-capsular antigens (fHbp, NHBA, and NadA) in MenB-4C has the potential to confer protection against other meningitis serogroups with common epitopes [47].",
            "startOffset": 31879,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 33288,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0285": {
                    "endOffset": 33287,
                    "startOffset": 33283
                }
            },
            "secId": "s0035",
            "sentence": "More recently, analysis of MenW isolates from the UK has shown high hSBA titres (\u22651:32) against all six strains in which MATS data predicted coverage following immunization with MenB-4C [57].",
            "startOffset": 33097,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 45022,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "More recent understanding of the immune system has questioned this concept.",
            "startOffset": 44947,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 45456,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "The reliance of the immune system purely on monospecific T-cell receptors is therefore biologically implausible.",
            "startOffset": 45344,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 17910,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, the sample size of clinical trials typically does not allow for individual estimates of cross-protection across a range of microorganism types because the prevalence of any single type is usually too low.",
            "startOffset": 17697,
            "title": "Introduction"
        },
        {
            "endOffset": 47488,
            "parents": [],
            "secId": "s0065",
            "sentence": "Therefore, the search for a \u201cuniversal\u201d influenza vaccine is underway.",
            "startOffset": 47418,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 22400,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22235,
                    "startOffset": 22231
                }
            },
            "secId": "s0020",
            "sentence": "While PHiD-CV employs cyanylation-mediated conjugation of 19F to a diphtheria toxoid carrier protein, which supposedly preserves the 19F epitope [16], PCV-7 uses reductive amination to conjugate 19F to a cross-reacting material 197 carrier, which may affect the 19F epitopes by opening one of the saccharide rings.",
            "startOffset": 22086,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 41225,
            "parents": [],
            "secId": "s0055",
            "sentence": "Often, these are involved in bacterial virulence or persistence.",
            "startOffset": 41161,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 29262,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 29261,
                    "startOffset": 29257
                }
            },
            "secId": "s0030",
            "sentence": "Using the same criteria, the pentavalent vaccine was found to have 76% (95% CI 64\u201389%) effectiveness against its vaccine types (single human rotavirus VP7 or VP4 antigen) and 81% (95% CI 43\u201393%) effectiveness against non-vaccine types (single human rotavirus VP7 or VP4 antigen not included in the pentavalent vaccine) [37].",
            "startOffset": 28938,
            "title": "Rotavirus"
        },
        {
            "endOffset": 20685,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "Various trials of PCV-7 and PHiD-CV have shown evidence of cross-protection against some non-vaccine serotypes in PCV-13 (Table 2).",
            "startOffset": 20554,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 48873,
            "parents": [],
            "secId": "s0070",
            "sentence": "This enhancement of the immune response by adjuvants is well-documented in the example of influenza vaccines already described.",
            "startOffset": 48746,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 19470,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0015",
            "sentence": "Interestingly, this vaccine also provides protection against leprosy (caused by the much more distantly-related M. leprae).",
            "startOffset": 19347,
            "title": "Vaccinia and mycobacteria"
        },
        {
            "endOffset": 40257,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0395": {
                    "endOffset": 40256,
                    "startOffset": 40252
                },
                "b0400": {
                    "endOffset": 40182,
                    "startOffset": 40178
                }
            },
            "secId": "s0045",
            "sentence": "Further, prior TBEV vaccination has been reported to enhance initial immune responses to Japanese encephalitis virus immunization in humans [80], and may also induce neutralizing antibodies against West Nile virus [79].",
            "startOffset": 40038,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 27372,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 27371,
                    "startOffset": 27367
                }
            },
            "secId": "s0030",
            "sentence": "In contrast to the important variability observed among G-and P-types, little diversity is found among VP6 subgroups and nonstructural protein 4 genotypes circulating in humans [35].",
            "startOffset": 27190,
            "title": "Rotavirus"
        },
        {
            "endOffset": 44025,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0440": {
                    "endOffset": 44024,
                    "startOffset": 44020
                }
            },
            "secId": "s0060",
            "sentence": "Specific antigenic determinants induce immune responses with antibodies recognizing and interacting with epitopes via complementary determinants (paratopes) in an area within the antibody variable region [88].",
            "startOffset": 43816,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 47208,
            "parents": [],
            "secId": "s0065",
            "sentence": "The content of seasonal influenza vaccines may vary each year, based largely on the epidemiological trends of the various circulating strains and clades but also on their antigenic characteristics.",
            "startOffset": 47011,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 40037,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0405": {
                    "endOffset": 40036,
                    "startOffset": 40032
                }
            },
            "secId": "s0045",
            "sentence": "For example, a TBEV vaccine has been reported to provide full protection against Omsk haemorrhagic fever virus infection in mice [81].",
            "startOffset": 39903,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 46499,
            "parents": [],
            "secId": "s0065",
            "sentence": "With this in mind, new vaccines can be designed by carefully selecting antigens that are conserved between pathogen types in order to elicit the broadest response and, hence, provide the widest protection.",
            "startOffset": 46294,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 16962,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is well known that vaccines can induce immune responses to antigens other than those contained in the vaccine, termed \u201ccross-reactivity\u201d.",
            "startOffset": 16822,
            "title": "Introduction"
        },
        {
            "endOffset": 21625,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 21533,
                    "startOffset": 21524
                },
                "b0045": {
                    "endOffset": 21624,
                    "startOffset": 21621
                },
                "b0070": {
                    "endOffset": 21533,
                    "startOffset": 21524
                },
                "b0075": {
                    "endOffset": 21533,
                    "startOffset": 21524
                }
            },
            "secId": "s0020",
            "sentence": "Interestingly, the cross-protection of PHiD-CV against 19A IPD (62\u201382%; Table 2 [8,14,15]) is almost as high as the vaccine-serotype protection of PCV-13 against 19A IPD (\u223c85%) [9].",
            "startOffset": 21444,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 32880,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0275": {
                    "endOffset": 32879,
                    "startOffset": 32875
                }
            },
            "secId": "s0035",
            "sentence": "A study evaluating 147 non-MenB isolates from Europe and Brazil, which measured hSBA responses using sera from subjects immunized with MenB-4C vaccine, reported responses against MenC, MenW, and MenY ranging from 45% to 90% [55].",
            "startOffset": 32651,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 23985,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 23984,
                    "startOffset": 23980
                }
            },
            "secId": "s0025",
            "sentence": "In a recent meta-analysis, AS04-HPV-16/18 and HPV-6/11/16/18 vaccines induced seropositivity to clinically important non-vaccine types, significantly more so for AS04-HPV-16/18 versus HPV-6/11/16/18 against HPV-31 and HPV-45 (Fig. 1A) [21].",
            "startOffset": 23745,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 26426,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 26425,
                    "startOffset": 26418
                },
                "b0150": {
                    "endOffset": 26425,
                    "startOffset": 26418
                }
            },
            "secId": "s0025",
            "sentence": "This seemingly lower cross-protection with the HPV-6/11/16/18 vaccine versus the AS04-HPV-16/18 vaccine has been attributed to their different adjuvants [29,30].",
            "startOffset": 26265,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 50548,
            "parents": [],
            "refoffsets": {
                "b0500": {
                    "endOffset": 50547,
                    "startOffset": 50542
                }
            },
            "secId": "s0070",
            "sentence": "For example, immunization with adenovirus-vectored centralized consensus hemagglutinin vaccine candidates (Adenovirus 4 and Adenovirus 5 vectors expressing H1, H3, and H5 consensus genes) has resulted in protection against challenge with lethal doses of heterologous influenza viruses in mice [100].",
            "startOffset": 50249,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 38390,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0045",
            "sentence": "These can cause a wide range of diseases including haemorrhagic fever, hepatitis, and encephalitis.",
            "startOffset": 38291,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 33620,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0290": {
                    "endOffset": 33619,
                    "startOffset": 33615
                }
            },
            "secId": "s0035",
            "sentence": "Indeed, in the UK, the Joint Committee on Vaccination and Immunisation has recognized that the MenB-4C vaccine is likely to provide some protection against other meningitis serogroups, including MenC [58].",
            "startOffset": 33415,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 43816,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0440": {
                    "endOffset": 43815,
                    "startOffset": 43811
                }
            },
            "secId": "s0060",
            "sentence": "There are several factors that support the wider range of B-cell specificity to antigens, one of which is the stimulation of the immune system early in the affinity maturation [88].",
            "startOffset": 43635,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 35885,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "The extent of seroprotection against related strains compared to vaccine strains varies widely.",
            "startOffset": 35790,
            "title": "Influenza"
        },
        {
            "endOffset": 35429,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0040",
            "sentence": "Influenza B viruses are divided into two antigenically distinct lineages (B/Victoria and B/Yamagata), and further by clades classically identified by representative strains (e.g. B/Brisbane/60/2008-like for one of the B/Victoria clade).",
            "startOffset": 35193,
            "title": "Influenza"
        },
        {
            "endOffset": 50665,
            "parents": [],
            "secId": "s0075",
            "sentence": "Many vaccines have been designed to target the most prevalent and/or most virulent strains of a pathogen.",
            "startOffset": 50560,
            "title": "Conclusions"
        },
        {
            "endOffset": 50976,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, it is now clear \u2013 from serological studies, clinical trials, and post-licensure data \u2013 that many vaccines can elicit cross-reactive immune responses that may have an important additional clinical impact (i.e. cross-protection) on disease caused by non-vaccine strains or variants of the same pathogen.",
            "startOffset": 50666,
            "title": "Conclusions"
        },
        {
            "endOffset": 31742,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0260": {
                    "endOffset": 31741,
                    "startOffset": 31737
                }
            },
            "secId": "s0035",
            "sentence": "The proportion of circulating MenB strains in different geographical populations that will likely be covered by MenB-4C has been estimated \u2013 using the Meningococcal Antigen Typing System (MATS) \u2013 to be 66\u201391% globally [52].",
            "startOffset": 31519,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 22085,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "One possible explanation is the different chemistry used to conjugate the polysaccharides to proteins.",
            "startOffset": 21983,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 30343,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0245": {
                    "endOffset": 30342,
                    "startOffset": 30338
                }
            },
            "secId": "s0035",
            "sentence": "However, development of a vaccine against meningococcal serogroup B (MenB) CPS had been hindered by potential molecular similarity to a human poly-sialyted neuronal cell adhesion molecule, which reduces immunogenicity in humans and raises concerns regarding the potential induction of autoimmune disease [49].",
            "startOffset": 30034,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 46293,
            "parents": [],
            "secId": "s0065",
            "sentence": "The data discussed in this review clearly show that many vaccine antigens can elicit cross-reactive and cross-protective immune responses.",
            "startOffset": 46155,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 48586,
            "parents": [],
            "secId": "s0070",
            "sentence": "Adjuvants also have the benefit of potentially improving cross-reactivity.",
            "startOffset": 48512,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 40350,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0045",
            "sentence": "However, it is not always clear to what extent cross-reactivity results in cross-protection.",
            "startOffset": 40258,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 27730,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 27729,
                    "startOffset": 27725
                }
            },
            "secId": "s0030",
            "sentence": "Indeed, rotavirus vaccines were specifically designed to mimic the cross-serotype immunity that occurs following natural infection with a rotavirus [36].",
            "startOffset": 27577,
            "title": "Rotavirus"
        },
        {
            "endOffset": 38290,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0045",
            "sentence": "The Flaviviridae family includes various arthropod-borne viruses, e.g. Yellow fever virus, dengue virus, Zika virus, West Nile virus, Japanese encephalitis virus, and tick-borne encephalitis (TBE) virus (TBEV).",
            "startOffset": 38080,
            "title": "Flaviviridae"
        },
        {
            "endOffset": 28010,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 28009,
                    "startOffset": 28005
                }
            },
            "secId": "s0030",
            "sentence": "Currently, two vaccines are widely available: a monovalent oral live attenuated human rotavirus vaccine containing the G1P[8] strain (Rotarix, GSK, Belgium) and a pentavalent human-bovine reassortant vaccine containing G1, G2, G3, G4, and P[8] strains (RotaTeq, Merck, USA) [37].",
            "startOffset": 27731,
            "title": "Rotavirus"
        },
        {
            "endOffset": 31351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0245": {
                    "endOffset": 31350,
                    "startOffset": 31346
                }
            },
            "secId": "s0035",
            "sentence": "Using this approach, MenB-4C (Bexsero, GSK, Belgium), a four-component vaccine combining fHbp, NadA, and NHBA antigens and an OMV antigen derived from a MenB strain associated with an outbreak in New Zealand, has been developed and is widely available [49].",
            "startOffset": 31094,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 41160,
            "parents": [],
            "secId": "s0055",
            "sentence": "In vaccination, the principal aim is to elicit strong immune responses (mainly antibody responses) to an antigen or antigens, which are typically accessible, surface-exposed immunogenic structures of the target pathogen.",
            "startOffset": 40940,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 34377,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0305": {
                    "endOffset": 34366,
                    "startOffset": 34362
                }
            },
            "secId": "s0035",
            "sentence": "Retrospective data from Norway suggest that there may be some decline in gonorrhoea incidence among MenB OMV vaccine recipients [61] (Table 1).",
            "startOffset": 34234,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 48212,
            "parents": [],
            "refoffsets": {
                "b0475": {
                    "endOffset": 48211,
                    "startOffset": 48207
                }
            },
            "secId": "s0070",
            "sentence": "With the move from whole pathogen to subunit and recombinant vaccines, vaccine antigens are expected to elicit a more specific \u2013 but less broad and less immunogenic \u2013 response [95].",
            "startOffset": 48031,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 25297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25296,
                    "startOffset": 25292
                }
            },
            "secId": "s0025",
            "sentence": "The prevalence of vaccine-type HPV was reduced by 89.1% (95% confidence interval [CI] 85.1\u201392.3%), but there were also reductions of comparable magnitudes in non-vaccine types: HPV-31, 93.8% (95% CI 83.8\u201398.5%); HPV-33, 79.1% (95% CI 64.2\u201389.0%); and HPV-45, 82.6% (95% CI 61.5\u201393.9%) [23].",
            "startOffset": 25007,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 49985,
            "parents": [],
            "refoffsets": {
                "b0480": {
                    "endOffset": 49984,
                    "startOffset": 49980
                }
            },
            "secId": "s0070",
            "sentence": "What is clear is that, by selecting and combining the most appropriate adjuvant components for a specific antigen, it is possible to design and formulate vaccines that deliver greater and broader protection (i.e. cross-protection) than existing vaccines [96].",
            "startOffset": 49726,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 18444,
            "parents": [],
            "secId": "s0005",
            "sentence": "Finally, we will discuss ways to leverage and improve this beneficial effect.",
            "startOffset": 18367,
            "title": "Introduction"
        },
        {
            "endOffset": 17181,
            "parents": [],
            "secId": "s0005",
            "sentence": "This can apply to related species within the same genus (e.g. administration of cowpox to protect against smallpox; or Mycobacterium bovis in the Bacillus Calmette\u2013Gu\u00e9rin [BCG] vaccine to protect against tuberculosis).",
            "startOffset": 16963,
            "title": "Introduction"
        },
        {
            "endOffset": 44946,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "secId": "s0060",
            "sentence": "Initially, it was thought that individual lymphocytes specifically recognized a single epitope of an antigen, with recognition of other antigens unlikely.",
            "startOffset": 44792,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 23744,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 23743,
                    "startOffset": 23739
                }
            },
            "secId": "s0025",
            "sentence": "A serological study of HPV-16/18 and HPV-6/11/16/18 showed that both vaccines elicited immune responses to non-vaccine HPV types (HPV-31/33/45/58) [20].",
            "startOffset": 23592,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 19622,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 19621,
                    "startOffset": 19618
                }
            },
            "secId": "s0015",
            "sentence": "Although the level of protection varies widely by study (20\u201390%), a meta-analysis has found overall vaccine efficacy of BCG against leprosy of 55% [4].",
            "startOffset": 19471,
            "title": "Vaccinia and mycobacteria"
        },
        {
            "endOffset": 41329,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 41280,
                    "startOffset": 41276
                },
                "b0250": {
                    "endOffset": 41328,
                    "startOffset": 41324
                }
            },
            "secId": "s0055",
            "sentence": "For instance, bacterial targets could include CPS [48] or OMVs in the case of meningitis vaccines [50].",
            "startOffset": 41226,
            "title": "Biological rationale for cross-reactivity"
        },
        {
            "endOffset": 18707,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18706,
                    "startOffset": 18703
                }
            },
            "secId": "s0005",
            "sentence": "The scope of this article is limited to antigen-specific cross-reactivity and does not include heterologous effects of vaccines mediated by non-specific immunomodulation, such as the protective benefits of BCG and measles vaccinations on all-cause mortality [2].",
            "startOffset": 18445,
            "title": "Introduction"
        },
        {
            "endOffset": 26264,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 26263,
                    "startOffset": 26259
                }
            },
            "secId": "s0025",
            "sentence": "Post-licensure data also indicate significant cross-protection against HPV-31, but not for the other types [28].",
            "startOffset": 26152,
            "title": "Human papilloma virus"
        },
        {
            "endOffset": 27004,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 27003,
                    "startOffset": 26999
                }
            },
            "secId": "s0030",
            "sentence": "These are further classified into glycoprotein (G) and protease-sensitive (P) serotypes/genotypes on the basis of their genomic sequence and the serological characteristics of their outer capsid proteins, VP7 and VP4, respectively [33].",
            "startOffset": 26768,
            "title": "Rotavirus"
        },
        {
            "endOffset": 36504,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0340": {
                    "endOffset": 36503,
                    "startOffset": 36499
                }
            },
            "secId": "s0040",
            "sentence": "This was significant when assessed by serology (0.09 vs 0.17 cases per person-year; vaccine efficacy 47%; p = 0.01), but not by reverse-transcription polymerase chain reaction (0.02 vs 0.02 cases per person-year; vaccine efficacy \u201332%; p = 0.61) [68].",
            "startOffset": 36253,
            "title": "Influenza"
        },
        {
            "endOffset": 47731,
            "parents": [],
            "refoffsets": {
                "b0470": {
                    "endOffset": 47730,
                    "startOffset": 47726
                }
            },
            "secId": "s0065",
            "sentence": "Approaches include eliciting a broader immune response that can confer protection against current seasonal influenza strains, or even targeting a protein or protein region that is conserved amongst both seasonal and pre-pandemic strains [94].",
            "startOffset": 47489,
            "title": "Rational vaccine design incorporating cross-reactivity"
        },
        {
            "endOffset": 48511,
            "parents": [],
            "refoffsets": {
                "b0480": {
                    "endOffset": 48433,
                    "startOffset": 48426
                },
                "b0485": {
                    "endOffset": 48433,
                    "startOffset": 48426
                },
                "b0490": {
                    "endOffset": 48433,
                    "startOffset": 48426
                },
                "b0495": {
                    "endOffset": 48433,
                    "startOffset": 48426
                }
            },
            "secId": "s0070",
            "sentence": "As reviewed by various authors [96\u201399], adjuvants can be used to improve the immune response to the target antigens.",
            "startOffset": 48395,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 40535,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0410": {
                    "endOffset": 40534,
                    "startOffset": 40527
                },
                "b0415": {
                    "endOffset": 40534,
                    "startOffset": 40527
                }
            },
            "secId": "s0050",
            "sentence": "Various human rabies virus vaccines are available, [82,83].",
            "startOffset": 40476,
            "title": "Rabies"
        },
        {
            "endOffset": 45730,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Biological rationale for cross-reactivity"
                }
            ],
            "refoffsets": {
                "b0450": {
                    "endOffset": 45729,
                    "startOffset": 45725
                }
            },
            "secId": "s0060",
            "sentence": "The capability of T-cell receptors to recognize different antigens is a biological need and cross-reactivity is one way that they may be able to do this [90].",
            "startOffset": 45572,
            "title": "Cross-reactivity as an intrinsic feature of the adaptive immune response"
        },
        {
            "endOffset": 30842,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0250": {
                    "endOffset": 30841,
                    "startOffset": 30837
                }
            },
            "secId": "s0035",
            "sentence": "While effective in controlling the strain-specific outbreaks for which they were developed, they cannot provide the necessary broader protective activity against the diverse range of MenB strains in global circulation [50].",
            "startOffset": 30619,
            "title": "Meningococcal meningitis"
        },
        {
            "endOffset": 49034,
            "parents": [],
            "refoffsets": {
                "b0320": {
                    "endOffset": 49033,
                    "startOffset": 49029
                }
            },
            "secId": "s0070",
            "sentence": "MF59 has been used in adjuvanted influenza vaccines for many years, inducing greater responses to heterotypic strains, compared with unadjuvanted vaccines [64].",
            "startOffset": 48874,
            "title": "Ways to improve cross-reactivity"
        },
        {
            "endOffset": 19193,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0015",
            "sentence": "Early smallpox vaccines contained material from cowpox lesions \u2013 which may have contained more than one species of poxvirus \u2013 while newer smallpox vaccines contain purified vaccinia virus, thus relying entirely on cross-protection.",
            "startOffset": 18962,
            "title": "Vaccinia and mycobacteria"
        },
        {
            "endOffset": 37366,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "refoffsets": {
                "b0345": {
                    "endOffset": 37107,
                    "startOffset": 37103
                }
            },
            "secId": "s0040",
            "sentence": "As reviewed by Chada et al. [69], various studies have shown that vaccines adjuvanted with MF59 or AS03 (an adjuvant system containing \u03b1-tocopherol and squalene in an oil-in-water emulsion) against pathogenic avian H5N1 can induce broad cross-clade immunity to antigenically diverse strains.",
            "startOffset": 37075,
            "title": "Influenza"
        },
        {
            "endOffset": 20425,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0020",
            "sentence": "These contain antigens of the serotypes as shown in Table 2.",
            "startOffset": 20365,
            "title": "Invasive pneumococcal disease"
        },
        {
            "endOffset": 19346,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Evidence of cross-reactivity/protection after vaccination"
                }
            ],
            "secId": "s0015",
            "sentence": "Another example of cross-protection is the BCG vaccine, which contains M. bovis, but protects against tuberculosis (caused by M. tuberculosis) (Table 1).",
            "startOffset": 19193,
            "title": "Vaccinia and mycobacteria"
        },
        {
            "endOffset": 41759,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although antigens usually differ between serotypes/genotypes in terms of their immunogenic and structural properties, they may retain common \u2013 and sometimes significantly conserved \u2013 features such as shared epitopes, usually a feature of phylogenetically closely related members of a pathogen species.",
            "startOffset": 41458,
            "title": "Biological rationale for cross-reactivity"
        }
    ],
    "docId": "S0264410X18316505",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "ivo.x.vojtek@gsk.com",
                "first": "Ivo",
                "initial": "I.",
                "last": "Vojtek"
            },
            {
                "email": null,
                "first": "Philippe",
                "initial": "P.",
                "last": "Buchy"
            },
            {
                "email": null,
                "first": "T. Mark",
                "initial": "T.M.",
                "last": "Doherty"
            },
            {
                "email": null,
                "first": "Bernard",
                "initial": "B.",
                "last": "Hoet"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.12.005",
        "firstpage": "539",
        "issn": "0264410X",
        "keywords": [
            "Adjuvants",
            "Cross-protection",
            "Cross-reactivity",
            "Vaccines"
        ],
        "lastpage": "549",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Would immunization be the same without cross-reactivity?"
    }
}